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ABSTRACT
As the most abundant and diverse biological agents in the biosphere phage have
significant roles in microbial ecology, acting both as lethal bacterial parasites and vehicles of
horizontal gene transfer. Phage/host coevolution drives optimization of phage codon usage for
use of host translational machinery, thus lowered correspondence between phage and host codon
usage reduces viral fitness. Some phage may partially bypass host translational selection on their
codon usage by encoding their own tRNAs, although the effects of these tRNAs on phage codon
usage and translation has not been well examined. This work explores the influence of phage
encoded tRNAs on viral codon usage via 1) codon usage analysis of Pseudomonas aeruginosa
phage phiKZ and EL; 2) attempted engineering of phiKZ populations with deoptimized proline
tRNAs; and 3) engineering and experimental evolution of mutant phiKZ strain, B1, with
duplicated aspartic acid, methionine, and proline tRNAs.
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CHAPTER ONE
INTRODUCTION
Bacteriophage
Viruses are the most abundant biological agents on Earth, in fact, an organism has yet to be
found that does not have some form of virus utilizing it as a host. Viruses are model parasites
which use the resources of a host organism to meet their own survival needs at the expense of
host fitness. Viral parasitism is so extreme that viruses themselves are not considered living,
rather most depend entirely on host cells to meet all their metabolic needs, including
reproduction. It follows that viral genomes are highly compact, coding only for factors essential
to commandeering hosts and converting them into virus factories. Although nonliving, viral
species evolve and adapt to changes in their environment to promote their own continuation just
as any living population does.
Bacteriophage (phage), viruses that only infect bacteria, are the most abundant, complex,
and possibly oldest of the viruses. These most prolific of viruses have served as essential tools in
biological research. Studies in phage led to the identification of DNA as the hereditary molecule,
breaking the genetic code, characterizing RNA, and a number of other discoveries upon which
molecular biology was founded (Clark & March 2006). The biosphere is thought to harbor as
many as 1031 phage virions at any given time and these particles overturn almost entirely in a
matter of days (Hatfull 2015). In all environments, phage are found to outnumber their bacterial
hosts (Bailly-Bechet 2007). The tremendous numbers and broad environmental range of phage
1
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spawns enormous diversity. No two identical strains of phage have ever been isolated twice in
nature (Pedulla et al. 2003).
Phage demonstrate a wide array of morphologies, genome structures and life cycle types.
The most common and most recognized phage structure consists of an icosahedral head, or
capsid, with a tail and tail fibers. However, this common virion structure is not the rule. Many
phage lack tails or tail fibers, some have lipoprotein envelopes, and some lack capsids entirely,
having instead a fibrous virion structure (Parasion et al. 2014). Phage are in part classified based
on their morphology which includes differences in capsid size, tail length, and tail type
(contractile or non-contractile), as well as their host range and life cycle (Ackerman & Nguyen
1983, Hendrix et al. 1999).
The genomes of phage also come in a variety of forms. Phage genomes may be single or
double stranded, circular or linear, singular or segmented, and may be composed of RNA or
DNA. Due to differences in their molecular stability, each genome composition is subject to a
different mutational rate. RNA and single stranded genomes mutate at a greater rate than double
stranded or DNA genomes (Duffy et al. 2008, Sanjuán et al. 2010). The majority of known
phage have double stranded (ds) DNA genomes, the most stable genome structure and the easiest
phage type to isolate in the lab (Serwer et al. 2007, Hatfull 2008). Order Caudovirales, dsDNA
tailed phage, make up what has long been considered to be the largest monophyletic group of
biological agents (Hertveldt et al. 2005, Hendrix et al. 1999).
Phage further demonstrate a range of lifestyles including lytic, lysogenic, chronic
infective, and pseudolysogenic (Mills et al. 2013), of which lytic and lysogenic life cycles are
most common. An illustrated overview of the lytic and lysogenic life cycles is shown in Figure 1.
All phage begin their life cycle with the adsorption process wherein the phage comes in contact
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with an appropriate bacterial host: one for which the phage’s capsid, tail or tail fibers are
specifically receptive, allowing the phage to attach itself to the bacterial cell wall. Phage are
unable to actively seek out hosts and so depend on host populations exceeding a threshold
density to maintain infection rates (De Paepe et al. 2014). Adsorbed phage proceed to puncture
the cell’s outer covering to inject its genome into the host cytoplasm. The cell may be penetrated
enzymatically, mechanically, or through some combination of the two (Briers et al. 2007,
Paradis-Bleau et al. 2007, Aksyuk et al. 2011). After injection, lytic and lysogenic phage diverge
in their infection strategy.

Figure 1. Diagram illustrating the lytic and lysogenic life cycles of phage.
Most phage are considered virulent, meaning they are strictly lytic. Following genome
injection, virulent phage quickly hijack the host cell’s machinery to produce the components of
phage progeny. Phage begin their replication by directly altering their host’s metabolism,
selectively activating and repressing host proteins to maximize production of phage components
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(Van den Bossche et al. 2016). Once the structural proteins of phage progeny have assembled, a
copy of the phage genome is then packaged in the newly formed capsid. Within phage order
Caudovirales, Myoviruses (family Myoviridae) form capsids by specific cleavage of structural
proteins performed by a phage encoded prohead protease which causes the capsid to shift from a
rounded shape to its mature icosahedral form (Thomas et al. 2012, Lecoutere et al. 2009). After
generating numerous progeny, virulent phage complete their life cycle by lysing, or bursting, the
host cell thus releasing progeny into the extracellular environment where the next phage
generation may find suitable new hosts in which to restart the process.
Temperate phage, the second most common phage type, use a lysogenic life cycle
wherein the phage alternates between lytic and lysogenic states. After injection, temperate phage
either immediately begin the lytic cycle or initiate lysogenic infection. When entering a
lysogenic state, phage typically splice their genomes into the genomes of their hosts. Once the
phage genome is incorporated into the host genome, the phage is referred to as a prophage and
has very limited gene expression (De Paepe et al. 2014). The prophage is propagated as the host
cell undergoes divisions, being replicated and vertically passed to host progeny. Prophage may
be triggered (induced) to enter the lytic cycle either spontaneously or by some environmental
stressor on the host such as nutrient deprivation or exposure to antibiotics (Wagner & Waldor
2002). Once induced, the prophage excises itself from the host genome and enters the lytic cycle.
Phage Ecology
As vehicles of horizontal gene transfer and natural bactericidal agents, phage are major drivers of
diversity for their surrounding microbiota. Phage and host have a predator/prey relationship: as
one population grows, the other declines. In natural systems, phage are thought to adhere to a
“Kill the Winner” growth model wherein phage replicate in the most abundant and fastest
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growing host available until that host is depleted (De Paepe et al. 2014). This Kill the Winner
system may be a major factor in the maintenance of bacterial diversity, as it never allows a single
bacterial player to dominate a given ecosystem (Mills et al. 2013).
These interactions are not limited only to environmental systems. In recent years as more
is understood about the human microbiome, it has become increasingly apparent that phage play
a distinct role in maintaining the balance of human microbiota. For example, the sudden
induction of prophage can cause sudden crashes of probiont populations in the human gut
microbiome, opening up the floor for pathogenic bacteria and disease in a manner similar to the
dysbiosis of gut microflora sometimes observed following antibiotic use (Mills et al. 2013).
Furthermore, the first direct link between human health and regular phage activity was recently
identified in a study which found disturbances of healthy core phage communities in the
gastrointestinal tract of individuals with GI disease (Manrique et al. 2016).
Phage Genome Structure: Lifestyles of the Genetically Promiscuous
Despite their abundance and ecological importance, little is known about phage diversity and
evolution. The majority of known phage have not had their genomes sequenced and of those that
have been sequenced, few have had their genomes fully annotated (Pope et al. 2014a). To date,
there are 2,269 phage genomes in the NCBI RefSeq collection
(https://www.ncbi.nlm.nih.gov/pubmed/26553804). The majority of phage sequences that are
currently available are for dsDNA phage, primarily Mycobacterium phage (for which the largest
sequence collection is available) and Escherichia coli phage (Pope et al. 2014a, Krylov et al.
2003, Murphy et al. 2013). Our current understanding of phage species largely comes from
laboratory studies of E. coli phage T4 and lambda, which have each proven to be indispensable
molecular biology tools (Krylov et al. 2003). Expanding knowledge of phage genome structure
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beyond that of a few model phage groups will be essential to fully utilizing phage as tools for
molecular biology and genetic engineering.
Phage reproduce rapidly, many virulent phage cycling through hosts in a matter of
minutes or hours, and with low fidelity, producing large numbers of variants with each
generation as a result of replication and packaging errors. The majority of these variants likely do
not survive (Pedulla et al. 2003). Additionally, phage undergo a tremendous amount of
horizontal gene transfer with other phage, their hosts, and any environmental microbes they
might otherwise encounter. Phage acquire and exchange significant portions of genetic material
through both homologous and non-homologous recombination with hosts and any coinfecting
phage or prophage (Murphy et al. 2013, Pedulla et al. 2003). Further, phage can act as general
transducers, carrying fragmented environmental, host, or other phage’s genetic material in their
capsids along with their genomes and transferring it to both hosts and coinfecting phage (Wagner
& Waldor 2002). Many phage possess genes sharing homology with a hugely diverse range of
microbes, indicating that phage are likely migratory, moving through a range of hosts over time
(Pope et al. 2014b, Hatfull 2015), and that phage likely gain new genetic material via horizontal
gene transfer from a shared pool of genetic elements within the local microbial community
which experiences regular turn over (Krylov et al. 2003).
Phage genomes are described as mosaic, consisting of a series of sequence cassettes that
have been swapped, mutated, and reswapped many times over. Each genomic mosaic is
structurally distinct, consisting of large fixed blocks containing both fixed essential and variable
nonessential genes. Blocks are often only recognizable by gene order and function, sharing little
or no nucleic acid or amino acid sequence similarity between phage groups (Hendrix et al. 1999,
Hertveldt et al. 2005). Although illegitimate recombination occurs throughout phage genomes on
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a grand scale, work in lambda phage indicates that only phage that happen to undergo
recombination at select genome regions remain functional (Pedulla et al. 2003). While overall
genome structure in terms of functional gene size and order indicates that most phage likely
descend from a common ancestor, the degree of horizontal gene transfer going on among phage
makes identifying clear phylogenetic relationships between phage based on sequence homology
nearly impossible (Hendrix et al. 1999, Krylov et al. 2003). Further complicating phage
phylogeny, no genes are conserved amongst all phages or even amongst all viruses, unlike all
cellular life.
Phage-Host Coevolution
Phage evolution is largely shaped by interactions with host species. Just as the phage is shaped
by its host, the host is in turn shaped by the phage. Phage and host are locked in a vicious red
queen coevolutionary dynamic: for each new defense the host develops against phage infection,
the phage counters with its own resistance strategies. Due to the swift and lethal nature of phage
infections, bacteria have developed a number of defenses against phage both to prevent and halt
infection. Bacteria may mask or change their surface receptors to prevent phage adsorption and
subsequent infection. Once phage have successfully injected their genomes, bacteria have a
number of systems in place which target foreign genetic material for destruction including DNA
restriction and modification systems, and systems inhibiting phage replication (Mills et al. 2013).
Host bacteria may degrade their own tRNAs to prevent phage translation upon infection (Pope et
al. 2014a). Many bacteria are found with CRISPR/Cas immune systems which retain
horizontally transferable cassettes of DNA from previous foreign DNA exposure and mobilize
Cas enzymes to destroy similar DNA when it is later encountered (Fineran & Charpentier 2012).
Although phage resistance is of high importance for bacteria, greater levels of phage resistance

8
come at a fitness cost (Mills et al. 2013) so bacterial populations must strike a balance between
phage resistance and overall fitness.
For every defense developed by their hosts, phage evolve new offensive strategies. Phage
have a competitive advantage over their hosts from the start having all the natural characteristics
of parasitic organisms: minimal survival needs, rapid reproduction, and the generation of prolific
numbers of progeny (Murphy et al. 2013). Additionally, even the most genomically stable phage
(those with dsDNA genomes) demonstrate significantly higher mutation rates than most bacteria
(Mills et al. 2013). Thus, for every defense bacteria develop against phage invasion, by sheer
chance of numbers and diversity, there is likely to be some virion among the phage population
that can bypass that defense. Beyond out competing hosts in terms of their rapid evolution, many
phage are found to encode genes that directly counter host immune systems such as phage
encoded DNA methyltransferases which methylate specific sites in the genome, protecting them
from cleavage by host restriction endonucleases. Ironically, phage likely inherited these enzymes
via horizontal gene transfer from host bacteria which use methyltransferases to protect their
genomes against their own restriction endonucleases (Murphy et al. 2013). Phage are also found
to dodge host restriction endonuclease systems by simply evolving to exclude restriction sites for
those endonucleases the host produces. The absence of specific restriction sites in phage has
proven to be a useful clue for tracking phage’s past use of alternate hosts as phage are often
found to lack restriction sites for enzymes their current hosts do not produce (Krylov et al. 2003).
Phage are also found to encode inhibitors for host RNA degradation systems that might
otherwise stunt phage replication (Van den Bossche et al. 2016).
The coevolutionary bond between phage and host goes well beyond competition as
phage’s propensity for swapping genetic material is not limited to other phage, phage both give
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and take genetic elements from their bacterial hosts. In fact, phage have been found to be
responsible for the transduction of a number of virulence factors to otherwise harmless bacteria
(Pedulla et al. 2003). Some prophage have been found to contribute capsid and tail fiber
sequences to their hosts which enable the bacteria to newly adhere to eukaryotic tissues. Phage
may also transfer phage encoded hyaluronidase genes (used to penetrate bacterial hosts) to host
genomes which may allow bacteria to penetrate the extracellular matrix components of animal
tissues. Phage can also facilitate the transfer of exotoxin genes and regulatory factors between
bacteria, altering bacterial pathogenicity (Wagner & Waldor 2002). Phage have been found to
pass cholera, Shiga, diphtheria, and Panton-Valentine toxin genes to their hosts, initiating
pathogenicity in a process known as “lysogenic conversion” (De Paepe et al. 2014).
Additionally, while there are no known phage-encoded antibiotic resistance genes, their role as
general transducers permits them to ferry any such genes they might encounter between hosts
(Wagner & Waldor 2002).
Codon Usage Bias
Microbes often exhibit biased codon usage wherein some synonymous codons are used
preferentially over others, this is the basis of the Genome Hypothesis which states that
synonymous codon usage preferences are similar within a given species’ genome but vary
between separate species (Ikemura 1985, West & Iglewski 1988). Codon usage biases are
generally found to be similar among closely related organisms and these biases become more
distinct with taxonomical distance (Ikemura 1985). Codon usage biases may evolve to optimize
RNA folding energies, to maximize translational efficiency, or may in some cases simply be a
byproduct of genome composition (Wua et al. 2004). Especially in genomes with significant GC
skew (being either highly GC or AT enriched), compositional bias appears to be the predominant
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determinant of genomic codon usage (Gupta & Ghosh 2001). Synonymous codon usage has
significant effects on mRNA folding, splicing, and half-life as well as playing a role in sequence
recognition by DNA binding proteins (Martínez et al. 2016).
Examination of codon usage can be highly informative with regards to gene expression
level and tRNA abundance. Codon usage bias is most prevalent in highly expressed genes and
conserved genes, while overall codon usage is observed to be more uniform in lowly and
moderately expressed genes (Gutiérrez et al. 1996, Pan et al. 1998, Lafay et al. 2000, BaillyBechet et al. 2007). Comparing the level of codon usage bias present in a group of genes can
thus be indicative of differences in expression level among genes as those genes with stronger
biases are likely expressed at higher rates than genes demonstrating weaker biases. Variation in
the degree of codon usage bias among genes with different expression levels arises as a result of
the strong selective pressure on highly expressed genes to utilize codons that optimize their
translational rate and efficiency, thereby reducing the metabolic cost of these genes’ high
expression. Similarly, strong biases occur in highly conserved genes which are under strong
selection to optimize fidelity of translation, as these genes are often essential to organism
survival. Translational selection is less rigorous in areas of the genome with low expression
where the metabolic costs of translation are lower, allowing the effects of genetic drift and
mutation to predominantly shape synonymous codon usage (Bulmer 1991).
Strong codon biases have, in most cases, been found to match cells’ tRNA pools:
preferred codons are those recognized by the cell’s most abundant tRNA species, and rare
codons correspond to less available tRNAs (Ikemura 1985, Pan et al. 1998, Martínez et al.
2016). Codons correspondent to tRNAs available in large concentrations can be translated
quickly and with greater fidelity; the more frequently these types of codons are used, the faster
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the average rate of elongation will be. In contrast, rare codons for which few charged tRNAs are
available can cause the translational machinery to either slow or halt, significantly reducing the
overall translational rate, total protein output, and can affect the final protein structure (Wua et
al. 2004). The effects of rare codon usage can be positive in some instances, such as when
slowed translation enables proper folding of regions of the polypeptide as the protein is being
produced without interference from the complete polymer (Albers & Czech 2016).
Codon usage biases are thought to form primarily by selection for translational
efficiency. Translation is highly metabolically expensive, consequently efficiency of translation
directly corresponds with cell growth rates. Organisms growing under competitive growth
conditions face tremendous selective pressure to use resources efficiently so it follows that codon
usage bias is most prominent in these organisms (Lafay et al. 2000). The optimization of
translation is a balancing act: selection favors highly biased genes using the most abundant
tRNAs enabling fast and high fidelity translation whereas genetic drift pushes genes toward a
state of random codon usage and lower accuracy translation (Tuller 2012). Translation may also
be optimized by favoring the use of codons with intermediate codon/anticodon interaction energy
in high expression genes as strong interaction energy can also stall the translation rate but weak
energies reduce translational accuracy (Grosjean & Fiers 1982).
Phage’s total (or near total for phage with self-encoded tRNAs) dependence on host
translational machinery has a significant effect on how phage codon usage biases evolve
(Cardinale et al. 2013). All viruses evolve under strong selective pressure to adhere to host
codon usage both to evade host immunity and to ensure translational efficiency. Phage are no
exception as most sequenced phage have been found to match or nearly match both their hosts’
codon usage preferences and GC content (Carbone 2008, Lucks et al. 2008, Cardinale & Duffy
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2011). Total matching of host GC content is rare, however, as phage tend to have more AT rich
genomes than bacteria, a common compositional trait of parasitic DNA (Carbone 2008, Lucks et
al. 2008). Viruses with highly mismatched codon usage compared to their host suffer fitness loss
(Grosjean & Fiers 1982, Bull et al. 2012). Fitness loss as a result of deoptimization of virus/host
codon usage correspondence can be substantial, so much so that viral codon deoptimization has
been used as a method to attenuate viral strains used in vaccines (e.g., Mueller et al. 2006, Bull
2015). Alteration of synonymous codon usage may reduce viral fitness by several mechanisms
including reducing translational efficiency, increasing the translational error rate, altering mRNA
secondary structure, and modifying viral regulatory signals. The effects of codon deoptimization
are individually small, but fitness loss accumulates linearly with the number of altered codons. A
virus engineered with hundreds of deoptimized codons will suffer substantial fitness loss and can
only regain wild type fitness through a long series of individual reversions to preferred codons.
Viruses attenuated in this way are thus especially suited for vaccines as fitness recovery is
expected to be too slow and gradual to allow virulence to redevelop during the vaccine exposure
period (Bull 2015).
Phage, like all viruses, are under strong selection pressure to utilize codon biases similar
to those of the host as these codons are optimized for the host translational machinery upon
which the phage is often largely dependent (Carbone 2008). Curiously, some phage are found to
have significantly different codon usage and GC content than their hosts, suggesting the level of
influence of host metabolism on shaping phage genome composition varies widely among
different phage types (Sahu et al. 2004). Disparities between phage and host codon usage may
arise as a result of replication biases of phage encoded DNA polymerases as phage without their
own polymerase are found to more closely match host biases than other phage groups (Kunisawa
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et al. 1998) or may indicate that the phage has only recently migrated into and begun to coevolve
with its current host (Sokolova et al. 2014). Alternatively, phage codon usage may differ from
the host’s in order to reduce translational competition with the host for tRNA use (Albers &
Czech 2016), either by utilizing phage encoded tRNAs corresponding to preferred phage codons
or evolving to favor codons infrequently used by the host. While most viruses are constrained to
correspondence with host codon usage to maintain their fitness, uniquely those phage species
which encode their own tRNAs may partially escape translational selection pressure by
providing their own translational machinery.
Phage Encoded tRNAs
Large, dsDNA viruses, most commonly phage, are the only viruses known to encode their own
tRNAs but little is known about the exact function of these genes. The most widely accepted
hypothesis regarding the function of phage tRNAs is that they are used to supplement the host
tRNA pool with self-encoded tRNAs corresponding to codons preferred in the phage genome
which occur infrequently in the host (Albers & Czech 2016). Phage vary dramatically in their
tRNA gene number, some having only one tRNA while some marine cyanophage have been
discovered with as many as 41 tRNA genes (Bailly-Bechet et al. 2007, Albers & Czech 2016).
The majority of phage with self-encoded tRNAs have only a small complement of tRNA genes,
so relief from host imposed translational selection is likely only present for a few codons.
However, all phage tRNAs have highly atypical structure compared to those of other organisms
(Pope et al. 2014a) and with tRNA modification comes room for wobble base pairing (Agris et
al. 2007, Das & Lyngdoh 2012). Wobble base pairing may allow phage with few tRNAs to
translate many of their own preferred codons without having to compete for use of host tRNAs.
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Aside from providing phage with some level of independence from host translational
machinery, it has also been proposed that phage tRNAs may be used as insertion points for
homing endonucleases (Brok-Volchanskaya et al. 2008). Phage tRNAs may have a role in
facilitating adaptation to new hosts, providing phage with some self-selected translational
machinery to work with as they evolve in a new cellular environment (Sahu et al. 1987, Pope et
al. 2014b). Much of the available evidence points to phage using their tRNAs to improve their
translational efficiency in a given host as many phage genomes are found to be enriched with
codons for self-encoded tRNAs (Kunisawa 2000, Bailly-Bechet et al. 2007). Whatever their
actual function, phage tRNAs appear to have functional importance as tRNA deletion has been
found to reduce phage fitness (Wilson 1973, Sahu et al. 2004, Bailly-Bechet et al. 2007)
Giant Pseudomonas Phage phiKZ and EL
Pseudomonas aeruginosa is a Gram negative bacterium with a 6.3 megabase pair (Mbp),
GC enriched genome (Grocock & Sharp 2002). It is host to a large number of known phage, the
best studied of which belong to the Phikzvirus genus of the Myoviridae family. Although more
studied than most P. aeruginosa phage, much about the genomes and coevolutionary relationship
of the Phikzviruses with their host remains either unknown or unexamined.
Pseudomonas phage phiKZ is the largest Phikzvirus with a 280,334 bp dsDNA, circularly
permuted genome with 306 identified open reading frames (ORFs). phiKZ is a virulent phage
with an unusually large icosahedral capsid, 120-130 nm in diameter, and has a long, 185 nm
contractile tail with short tail fibers (Mesyanzhinov et al. 2002, Krylov et al. 2007). It has long
been known to be a general transducing phage because its large isocahedral capsid allows space
for non-phage (often host) DNA (Jusupova et al. 1982). phiKZ shares minimal amino acid
sequence similarity and almost no nucleotide sequence homology with even its closest relatives
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in the Phikzvirus genus, which in turn are all highly diverged from all other Myoviruses at both
the amino acid and nucleotide levels. phiKZ along with the other members of the Phikzvirus
genus are thus an evolutionarily unique and distinct branch of the Myoviridae family
(Mesyanzhinov et al. 2002). The phylogenetic relationships between the Phikzviruses are shown
in Figure 2.

Figure 2. Genome comparisons of members of the Phikzvirus genus. In the two phylogenetic
trees based upon (A) the major capsid protein and (B) the TerL protein, the branch lengths are
proportional to the number of substitutions per site; branch support values are indicated on the
branches in red (image reproduced from Adriaenssens et al. 2016). (C) Schematic comparison of
the EL and phiKZ genomes (image reproduced from Hertveldt et al. 2005). Dark grey boxes
indicate regions of proteins sharing amino acid similarity between the two genomes. Light grey
boxes indicate regions sharing amino acid similarity, but with reshuffled gene order within the
regions. Regions with dotted boxes are unique to the specific phage.
phiKZ is unusual among phage for a number of reasons. First, phiKZ has a highly
dissimilar GC content compared to its host (Hertveldt et al. 2005). phiKZ’s genome is highly AT
enriched, having a GC content of only 36.8 % while its host has a GC content of 65-67.2%,
depending on the strain (West & Iglewski 1988, Krylov et al. 2003). phiKZ is the only phage to
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have been found to encode a multi-subunit RNA polymerase (Yakunina et al. 2015).
Additionally, phiKZ has a rod-like protein structure in its capsid known as the inner body which
sits at a 20° angle to the tail shaft. phiKZ virions with visible inner body structures are shown in
Figure 3. The inner body is thought to be used as a spool for the phage’s large genome and may
also participate in storage of proteins used to initiate infection as the inner body is injected into
the host along with the genome (Thomas et al. 2012, Wu et al. 2012). The inner body structure
appears to be conserved among the Phikzviruses (Thomas et al. 2012, Sokolova et al. 2014).

Figure 3. Scanning electron micrograph of phiKZ virions with inner body structures visible in
their capsids (image reproduced from Sokolova et al. 2014).
Although phiKZ is one of the most studied Pseudomonas phage species, its genome
remains poorly annotated, due in large part to its limited homology with other microbes
(Hertveldt et al. 2005, Thomas et al. 2012). Of phiKZ’s 306 genes, only about 30 have been
functionally annotated, most of which are structural proteins that are better conserved amongst
Myoviruses than other proteins (Lecoutere et al. 2009, Thomas et al. 2012, Thomas & Black
2013, Mesyanzhinov et al. 2002, Krylov et al. 2003, Kurochkina et al. 2009, Aksyuk et al. 2011,
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Sycheva et al. 2012, Fokine et al. 2008, Briers et al. 2007, Briers et al. 2008, Paradis-Bleau et al.
2007, Yakunina et al. 2015).
phiKZ’s endolysin, gene product (gp) 144, is among the best studied of phiKZ’s proteins
(Briers et al. 2007, Briers et al. 2008, Fokine et al. 2008, Paradis-Bleau et al. 2007). phiKZ’s
gp144 is its primary endolysin used to rupture P. aeruginosa cells during the lytic stage of phage
infection. phiKZ also has a secondary endolysin, gp181, which is used to enzymatically penetrate
its host following adsorption allowing the phage’s tail tube to puncture the host and inject the
phage genome (Briers et al. 2007, Briers et al. 2008, Paradis-Bleau et al. 2007). Phage
endolysins are of special interest as purified phage endolysins can be used to clear bacterial
infections in a species specific manner (Nelson et al. 2001). Among the other non-structural
proteins of phiKZ that have been functionally annotated are its non-virion RNA polymerase
proteins (gp55, gp68, gp71, gp72, gp73, gp74, and gp123) (Yakunina et al. 2015), the virion
RNA polymerase beta subunit (gp180) (Thomas et al. 2012), the prohead protease (gp175)
(Thomas et al. 2012, Thomas & Black 2013), and “Dip”, a protein used to competitively inhibit
host initiated RNA degradation (gp37) (Van den Bossche et al. 2016). The phiKZ genome also
encodes for six different tRNAs which correspond to amino acids methionine, asparagine,
aspartic acid, threonine, proline and leucine utilizing anticodons CAU, GUU, GUC, UGU, UGG,
and UAA respectively (Mesyanzhinov et al. 2002) (Figure 4).

Figure 4. Location of tRNAs within the phiKZ genome sequence.
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While little is known about phiKZ compared to more studied phage like T4 and lambda,
even less is understood about Pseudomonas phage EL. EL has a 211,215 bp circularly permuted
dsDNA genome with 201 ORFs (Lecoutere et al. 2009). EL has a capsid diameter of 140 nm and
a 200 nm long tail (Hertveldt et al. 2005). Like phiKZ, EL is virulent and has a substantially
more AT rich genome than P. aeruginosa with a GC content of 49.3%. EL and phiKZ are highly
similar in terms of both their morphology and proteome. Further, amino acid sequence similarity
and shared genomic structural motifs indicate that EL shares a recent common ancestor with
phiKZ (Hertveldt et al. 2005, Lecoutere et al. 2009). Although EL has long been considered a
member of the Phikzvirus genus, a proposal to create a new genus, ELvirus, with Pseudomonas
phage EL as its type virus is currently under review with the International Committee on the
Taxonomy of Viruses (Adriaenssens et al. 2016). As the phylogenetic trees (Figure 2A and B)
for members of the Phikzvirus genus show, phiKZ and EL are significantly diverged from each
other despite sharing similar ‘blocks’ of coding regions (Figure 2C).
The EL DNA polymerase, gp21, is the first DNA polymerase to be identified among the
Phikzviruses as their polymerases are extremely diverged from all other known DNA
polymerases (Kazlauskas & Venclovas 2011). Perhaps the most interesting known feature of
EL’s genome is gp146, an ortholog of GroEL chaperonins, the first chaperonin protein found to
be encoded in a phage genome (Hertveldt et al. 2005, Kurochkina et al. 2012). The structural
genes of EL have been identified experimentally by SDS-PAGE but few have been annotated
(Lecoutere et al. 2009). The penetrative and lytic endolysins of EL, gp183 and gp181, have been
identified based on amino acid sequence similarities with those of phiKZ (Briers et al. 2007). EL
encodes a single tRNA for amino acid threonine using anticodon CGU (Hertveldt et al. 2005).
Beyond these, almost no EL genes have been functionally annotated, both because EL has
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seldom been examined and, as is also the case with phiKZ, EL’s genes and proteins demonstrate
little to no homology with any other known organisms.
Evaluation of the Effects of Phage tRNAs on Codon Usage
This work aims to investigate how codon usage evolves in P. aeruginosa large phage with
respect to phage-encoded tRNAs by examining the codon usage of two of the most extensively
studied P. aeruginosa phage, phiKZ and EL. The genomes of these phage have been fully
sequenced, assembled, and sufficiently annotated to allow for comparisons to be made between
genes of different types and expected levels of expression. Codon usage analysis will be used to
determine whether these phage species demonstrate any apparent preference for codons
corresponding to their own tRNAs and to compare the degree of translational selection for codon
usage correspondence with host bacteria experienced by phage with different numbers of selfencoded tRNAs. In order to examine the functions of phage tRNAs in more detail, two mutant
phiKZ strains were designed with either altered tRNA anticodons or copy numbers. Engineering
of a phiKZ mutant strain with a deoptimized proline tRNA intended to observe the effects of
altered self-tRNA isoreceptor type on phage fitness was started but was not successfully
completed. A mutant strain of phiKZ with a tandemly duplicated region containing its aspartic
acid, methionine, and proline tRNAs was engineered to increase the relative abundance of these
tRNAs. Evaluation of the effects of tRNA duplication on phage codon usage following
experimental evolution will help clarify the relationship between phage tRNA availability and
phage codon usage.

CHAPTER TWO
METHODS
Part I: Analysis of Phage Codon Usage
Sequence Selection
The coding sequences for the RefSeq records of Pseudomonas phage phiKZ (Accession:
NC_004629.1) and Pseudomonas phage EL (Accession: NC_007623.1) were manually pulled
from NCBI’s GenBank. Coding sequences were retained for analysis only if they exceeded 150
bp (50 codons) in length in order to avoid analyzing genes that might demonstrate codon usage
biases resulting solely from small total codon counts.
In order to ensure that sequences for phiKZ were essential genes to phage fitness and
therefore reflective of the phage’s native codon usage, sequences for phiKZ were retained if they
were either experimentally confirmed to code for functional gene products or if their protein
products shared more than 90% amino acid sequence identity with two closely related phiKZ
strains, Pseudomonas phage KTN4 (Accession: KU521356.1) and Pseudomonas phage PA7
(Accession: JX233784.1), for which complete genome sequences are available. Maintenance of
these genes to such a high threshold of similarity across multiple strains was considered
evidential that these genes are likely essential to phage fitness. Similar selection criteria could
not be applied to EL as whole genome sequences for near EL relatives were not available.
Those sequences for EL sharing more than 90% amino acid sequence identity with P.
aeruginosa strains were rejected as such high sequence similarity indicates that these genes were
20
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likely horizontally acquired from the host and thus do not reflect the codon usage of the phage.
No phiKZ sequences were identified with 90% or more amino acid sequence similarity with P.
aeruginosa proteins. Sequence similarity to related phage strains and P. aeruginosa was
evaluated from each gene product’s UniProt UniRef90 database entry which lists clusters of
UniProtKB sequences which share at least 90% sequence identity and 80% sequence overlap
with the cluster’s longest sequence. Identical sequences in UniProtKB are combined in UniRef
databases so clusters included sequences from multiple, unspecified P. aeruginosa strains.
Sequences for both phiKZ and EL were rejected if the sequence possessed properties of
mobile elements including HNH endonucleases and recognizable intein sequences in order to
avoid inclusion of foreign sequences in the codon usage analysis. Mobile elements were
identified previously during comparative sequence analysis of the phiKZ and EL genomes
(Hertveldt et al. 2005).
The number of genes meeting the aforementioned selection criteria are listed in Table 1.
In total 258 coding regions passed all filters for phiKZ and 166 passed all filters for EL. A
complete listing of these coding regions, including their gene identification number and
predicted product, is located in Appendix A (for phiKZ) and Appendix B (for EL).
Criteria for Gene Selection
phiKZ
Total number of genes
306
Number of genes >150 bp in length
305
Number of experimentally verified genes
74
Number of genes with mobile element motifs
4
Number of non-experimentally verified genes sharing >90% amino acid
184
identity with KTN4 and PA7
Number of genes sharing >90% amino acid identity with P. aeruginosa
0
Total number of genes retained for codon usage analysis
258
Table 1. Number of genes meeting the criteria for selection for codon analysis.

EL
201
201
64
7
N/A
28
166
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Codon Usage and Statistical Analyses
Codon usage and statistical analyses were performed using CodonW 1.4 (Peden 1999,
Peden 2005) available from http://codonw.sourceforge.net/, except where otherwise noted.
CodonW is a bioinformatics software tool that can be used to calculate codon counts, relative
synonymous codon usage, codon adaptation index, effective number of codons, correspondence
analysis, and a number of other analyses on codon usage for a given set of input sequences.
Relative Synonymous Codon Usage
Relative synonymous codon usage (RSCU) values are calculated as the ratio of observed
codon usage to expected codon usage wherein all codons are used equally for each amino acid.
RSCU values normalize codon usage across sequences which differ in amino acid composition
and length. Codons with RSCU values greater than 1 are used more often than expected and
codons with RSCU values less than 1 are used less frequently than expected (Sharp & Li 1987).
RSCU values were calculated for both the phiKZ and EL sequence sets.
RSCU values of codon usage for 40 known high expression genes of P. aeruginosa
PAO1 (Sharp et al. 2005) were previously calculated utilizing internal laboratory software
developed in C++ based on the reference sequence of P. aeruginosa PAO1 downloaded from
NCBI (GenBank: NC_002516). These RSCU values and other codon usage metrics are available
through the Codon Bias Database at www.cbdb.info (Hilterbrand et al. 2012).
Correspondence Analysis
Correspondence analysis (COA), a form of multivariate statistical analysis, was
performed for both codon counts and RSCU values of the phiKZ and EL coding sequence sets.
COA plots genes along 59 continuous axes based on trends in their use of the 59 sense codons
for which synonymous codons exist; thus, stop codons and codons for methionine and
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tryptophan are excluded. This analysis is based on a contingency table with measures of codon
usage (e.g. codon count or RSCU values) as columns and genes as rows (Peden 1999).
The 59 dimensional plot is built by measuring the variance between individual row and
column values and the variance between individual values and the average row and column
profiles (determined from the marginal frequency distribution over the sum of all rows or all
columns) using a chi-square metric. The total variance or inertia of each row or column is
calculated as the weighted sum of the chi-square distances calculated between each row value
and the average row profile or between each column value and the average column profile. COA
then decomposes the 59 dimensional plot produced down to four axes of variation which have
maximum inertia but minimum variance between the axes and the original row and column
values. These are the axes with the strongest correlation coefficients which maximize the
correspondence between genes and their codon usage. Each of the four resulting axes of
variation accounts for subsequently less variation than the last. Axis 1 accounts for the most
variation in codon usage among the genes, axis 2 accounts for the second most variation (often
substantially less than axis 1), and so on (Sourial et al. 2010).
COA thus effectively reduces high dimensional data down to a more interpretable, low
dimensional data set explaining the variance among the original data.
Frequencies of Nucleotides at Third Codon Positions
The relative frequencies of each nucleotide at the third codon position were calculated for
all analyzed genes. Calculations were made for GC 3, A3, T3, G3, and C3. GC3 is a measure of the
relative frequency of guanine and cytosine at the third codon position calculated as (G+C) / (G +
C + A + T). A3, T3, G3, and C3 measure the relative frequency of adenine, thiamine, guanosine
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and cytosine at the third codon position respectively. These frequencies are calculated as A / (G
+ C + A + T), T / (G + C + A + T), G / (G + C + A + T), and C / (G + C + A + T).
Effective Number of Codons
The effective number of codons, or Nc, values were calculated for each gene. Nc is a
measurement of the non-uniformity of synonymous codon usage in a sequence (Wright 1990).
Nc values range from 20-61, where 20 represents an extreme bias wherein only one codon is used
for each amino acid in the gene and 61 represents a case where synonymous codons appear to be
used randomly (i.e., no bias present).
Expected Nc values under random codon usage were used as a basis of comparison for the
Nc values observed. Expected Nc values were calculated using the following adjusted version of
Wright’s formula: Nc = 2.5 - s + (29.5 / (s2 + (1 – s)2), where s = GC3. The resulting expected Nc
values are more accurate and thus more closely demonstrate the relationship between observed
Nc values and their expected values than those calculated by Wright’s original formula (Liu
2013).
Correlation of Axis 1 Position with Third Codon Position Content
Spearman’s rank correlation of genes’ axis 1 positions for correspondence analysis of RSCU
values with genes’ axis 1 positions from correspondence analysis of codon counts, as well as
genes’ axis 1 positions (determined by correspondence analysis of codon counts) with GC 3, A3,
T3, G3, and C3 values (Ghosh et al. 2000) was performed in R 3.1 (R Core Team 2013).
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Part II: Engineering Mutant phiKZ Populations
Strategy I: Generating phiKZ Populations with Deoptimized Proline tRNAs
PhiKZ Growth, Harvest, and DNA Extraction
P. aeruginosa str. ATCC 15692 was obtained from ATCC (Manassas, VA). Liquid
cultures were grown for a minimum of 18 h at 37°C, shaking at 120 rpm in LB broth (10 g bactotryptone, 5 g yeast extract, 10 g NaCl per 1 L dH2O). Liquid cultures exceeding 3 ml in volume
were grown with sterile glass beads to disrupt biofilm formation. Bacterial lawns were prepared
by gently swirling together a 3:1 ratio of warm, liquid LB soft agar (SA) (LB broth + 0.7%
agarose) to turbid P. aeruginosa liquid culture until well mixed and pouring approximately 1.5
ml of the mixture over a 1.7% agar LB plate. The mixture was quickly spread evenly using a
cool, flame sterilized bacterial spreader. The plate was then allowed to solidify. Pseudomonas
phage phiKZ (HER153) was obtained from the Félix d’Hérelle Reference Center for Bacterial
Viruses (Quebec City, Canada). Liquid phiKZ was taken from stock culture (stored in 50/50 v/v
glycerol at -80°C) and was spotted onto the dried lawn in 10 μl increments and allowed to dry.
Five to seven spots were added per plate. Plates were incubated at 37°C (18-24 h).
PhiKZ plaques were harvested by gently removing the SA in the plaque area with a cool,
flame sterilized scoopula. All plaques from a single plate were placed in a sterile 1.5 ml
microcentrifuge tube filled with 0.8% saline solution. Plaque samples were then flatbed vortexed
for 3 min then centrifuged for 1 min at 10,000 g. The supernatant was removed to a fresh 1.5ml
microcentrifuge tube and mixed with 20 μl 10% chloroform in order to destroy any remaining
host cells. PhiKZ samples were stored at 4°C.
Viral DNA was extracted from phiKZ samples using a MO Bio Laboratories UltraClean
Microbial DNA Isolation Kit (Carlsbad, CA). The manufacturer’s protocol was followed exactly
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with the following alterations to increase DNA yield: optional heating step 3 in which samples
were placed in a 70°C heating block for 10 min was used and only 30 μl (rather than the
recommended 50 μl) of MD5 elution buffer (TE buffer) was used in the final protocol step. DNA
samples were stored at -20°C.
PCR Amplification of Genomic Region Targeted for Mutagenesis
Due to the large size of phiKZ’s genome (>280 Kbp) a subsection of phiKZ’s genome
was amplified by PCR for use in site directed mutagenesis. All PCR primers were designed using
Primer3 (Rozen & Skaletsky 1998) based on the phikZ reference sequence retrieved from NCBI
(Accession: NC_004629.1).
The following primer pair was designed: 5’-GGGGAATTCGCCACTTACCCGATGGT3’ (phiKZFUNKfor) and 5’-GGGTCTAGACCGTCGCGAAATATCCA-3’ (phiKZFUNKrev).
These primers amplify a 3,405 bp region (hereafter referred to as phiKZFUNK) of phiKZ’s
genome containing its proline, leucine, threonine and arginine tRNAs. phiKZFUNK spans base
pairs 271,140 through 274,544 of phiKZ’s genome. The forward primer includes an added
restriction site for EcoRI (5’-GAATTC-3’) and the reverse primer includes an added restriction
site for XbaI (5’-TCTAGA-3’), which are underlined in each primer sequence above. These
restriction sites allow phiKZFUNK to be inserted into cloning vectors. All PCR primers were
synthesized by Eurofins (Huntsville, AL).
The 50 μl PCR mixture for the production of phiKZFUNK consisted of 5 μl 10x
Invitrogen PCR Reaction Buffer (-MgCl2), 1 μl 10mM dNTPs, 1 μl 100μM phiKZFUNKfor
primer, 1 μl 100 μM phiKZFUNKrev primer, 1 μl Invitrogen KB extender, 1.5 μl 50 mM MgCl 2,
1 μl template phiKZ DNA (minimum concentration 150 μg/ml), 0.2 μl Invitrogen Platinum Taq
Polymerase, and nuclease-free water to 50 μl. All DNA concentrations were determined using a
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Thermo Fisher Scientific (Waltham, MA) Qubit-Fluorometer and dsDNA BR Assay Kit
following the manufacturer’s protocol exactly.
PhiKZFUNK was generated using the following thermalcycling conditions: 94°C 5 min,
40 cycles of: 94°C 1 min, 55°C 1 min, 62.6°C 5 min, and 62.6°C 10 min. Two negative controls
using nuclease-free water and whole P. aeruginosa cells in place of phiKZ DNA were run for the
phiKZFUNK primers using the same thermalcycling conditions.
Amplification of phiKZFUNK was confirmed by running PCR products in a 1.2%
agarose gel containing ethidium bromide for 45 min at 90 V with a DNA ladder, yielding a
single bright band of the expected ~3,400 bp size. PCR products were purified using an EZNA
Cycle Pure Spin kit (Omega Bio-tek, Norcross, GA). The kit protocol was followed exactly, with
only 30 μl of elution buffer used in the final protocol step to improve DNA yield. Samples were
stored at -20°C.
Cloning phiKZFUNK
The purified phiKZFUNK PCR product and pUC19 vectors were digested using Thermo
Fisher Scientific (Waltham, MA) Fast Digest XbaI (5’-TCTAGA-3’) and EcoRI (5’-GAATTC3’) restriction enzymes, following the manufacturer’s plasmid DNA digest protocol exactly.
Restriction enzymes were heat inactivated for 20 min at 65°C.
XbaI/EcoRI double digested phiKZFUNK was then ligated into XbaI/EcoRI double
digested pUC19 vectors using Stratagene (San Diego, CA) T4 DNA Ligase by mixing 0.5 μl
pUC19 (500 ng/μl), 1 μl phiKZFUNK (minimum concentration 100 μg/ml), 1 μl 10x Ligase
Buffer, 1 μl 10mM ATP, 0.5 μl 4U/μl T4 DNA Ligase, and 6 μl of nuclease-free water. The
ligation mixture was incubated for 1 h at 25°C. The ligase was heat inactivated for 10 min at
65°C.
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Plasmids with successful insertions were separated from remaining ligation reactants by
gel electrophoresis using a 1.2% agarose gel, run at 90 V for 45 min. Gel bands corresponding to
the size of the plasmid with phiKZFUNK inserts (~6,400 bp) were cut from the gel. Gel band
DNA was purified using a Thermo Fisher Scientific (Waltham, MA) GeneJET Gel Extraction
Kit following the manufacturer’s protocol exactly. DNA yield was improved by using only 30 μl
of elution buffer in the final protocol step.
Purified pUC19 plasmids containing phiKZFUNK were transformed into JM109
chemically competent E. coli (Promega, Madison, WI) by the following procedure: (1) 5 μl
plasmid DNA was added to 50 μl gently thawed JM109 E. coli cells; (2) cells were allowed to
rest on ice for 30 min; (3) cells were heat shocked in a 42°C water bath for 30 s and immediately
placed back on ice for 2 min; and (4) cells were added to 250 μl super optimal broth with
catabolite repression (SOC) media (0.5% yeast extract, 2% bacto-tryptone, 10 mM NaCl, 2.5
mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) prewarmed to 37°C and
incubated 1 h at 37°C, shaking at 120 rpm.
60 μl of the inoculated SOC was then mixed with 3 ml warm, liquid LB SA media
premixed with 30 μl Ampicillin, 20 μl X-Gal and 10 μl IPTG to allow blue/white and antibiotic
resistance screening of transformants. Inoculated LB SA was then spread evenly over an LB
plate and allowed to dry. Transformants were allowed to grow for 18 h at 37°C. Resulting white
colonies were individually collected using micropipette 200 μl capacity tips then ejected into 3
ml LB broth. Cultures were grown for 24-48 h at 37°C, shaking at 120 rpm.
Cloned vectors were extracted from transformant cultures using a Thermo Fisher
Scientific (Waltham, MA) GeneJET Plasmid Miniprep Kit. The manufacturer’s protocol was
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followed exactly, using only 40 μl elution buffer in the final step to improve DNA yield.
Samples were stored at -20°C.
Site Directed Mutagenesis
Miniprep samples with a minimum concentration of 100 μl/ml were used as templates for
site directed mutagenesis PCR to alter the proline tRNA anticodon. Mutagenic PCR was
performed using a Thermo Fisher Scientific (Waltham, MA) Phusion Site Directed Mutagenesis
Kit. Mutagenesis primers were designed in Primer3 (Rozen & Skaletsky 1998), with the third
position of the anticodon manually altered from base A to base C. This alteration generated the
desired point mutation in the proline tRNA. Mutagenesis primers were designed to change the
proline anticodon from 5’-UGG-3’ to 5’-GGG-3’. The forward primer designed was 5’[Phosphate]GCTCCCCAAGCAGGCGCGCTACCA-3’ (SuperProF) (the altered base is
indicated) and the reverse primer designed was 5’[Phosphate]AGACTCGAACTCCCGACATCCT-3’ (SuperProR). Mutagenesis primers must be
phosphorylated at their 5’ ends. Primers were synthesized by Eurofins (Huntsville, AL). Mutant
phiKZFUNK/pUC19 vectors generated by mutagenic PCR are hereafter referred to as SuperPro
amplicons.
Mutagenesis PCRs were performed using 50 μl PCR solutions consisting of 10 μl 5x
Phusion HF Buffer, 1μl 10 mM dNTPs, 1 μl 100 μM SuperProF, 1 μl 100 μM SuperProR, 1 μl
template phiKZFUNK/pUC19 DNA (minimum concentration 100 μg/ml), 0.5 μl 2 U/μl Phusion
II Hot Start DNA Polymerase, and 35.5 μl nuclease-free water.
SuperPro amplicons were generated using the following thermalcycling conditions: 98°C
1 min, 25 cycles of: 98°C 30 s, 60.4°C 1 min, 66.7°C 8 min, and 66.7°C for 10 min. A negative

30
control using only nuclease-free water in place of a DNA template using the same
thermalcycling conditions was also run.
Mutagenic PCR generated both the desired 6,091 bp SuperPro amplicon and a truncated
amplicon (~500 bp) when visualized in a 1.2% agarose gel. The SuperPro amplicon was isolated
using a Thermo Fisher Scientific (Waltham, MA) GeneJET Gel Extraction Kit. The kit protocol
was followed exactly using only 30 μl of elution buffer in the final protocol step to increase
DNA yield.
SuperPro amplicons were circularized using Stratagene (San Diego, CA) T4 DNA
Ligase. A 10 μl ligation solution consisting of 1 μl purified SuperPro amplicon (minimum
concentration 100 μg/ml), 2 μl 10x Fast Ligation Buffer (w/ATP), and 6.5 μl of nuclease-free
water was mixed. Then 0.5 μl 5U/μl T4 DNA Ligase was added and the solution was vortexed a
second time. The ligation solution was incubated at 25°C for 1 h then allowed to chill on ice for
10 min before being cloned using the previously described procedure used to clone
phiKZFUNK/pUC19 vectors. Twenty white colonies generated were each grown in 3 ml LB
broth for 48 h at 37°C, shaking at 125 rpm. Plasmid DNA was extracted from 1 ml of each E.
coli culture by the previously described miniprep procedure used to extract cloned
phiKZFUNK/pUC19.
SuperPro minipreps were prepared for sequencing by mixing 1 μl of miniprep sample
with 0.5 μl of a 100 μM sequencing primer and 3.5 μl nuclease-free water. Each miniprep sample
was sequenced twice, once with the forward sequencing primer, ProleuF with sequence 5’GAATAGCGTAAAGAGCTGTTCC-3’ and a second time with the reverse sequencing primer
ProleuR with sequence 5’-TGCGAAGTGACCGATGTC-3’. Sequencing primers were designed
using Primer3 (Koressar & Remm 2007, Untergasser et al. 2012) and were synthesized by
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Eurofins (Huntsville, AL). These primers cover the region of phiKZ’s genome spanning base
pairs 273,189 through 273,561 and fall within 500 bp of phiKZ’s proline and leucine tRNAs,
effectively targeting these tRNAs for Sanger sequencing with read lengths of ~1,000 bp. Sanger
sequencing was performed by GeneWiz sequencing services (South Plainfield, NJ). Sequencing
results confirmed that two of the twenty miniprep samples sequenced contained the desired point
mutation.
The remaining E. coli culture with plasmids confirmed by sequencing to have the desired
mutation was grown in 500 ml LB broth for 24 h at 37°C, shaking at 125 rpm in an Erlenmeyer
flask. A Thermo Fisher Scientific (Waltham, MA) GeneJET Plasmid Midiprep Kit was then used
to extract SuperPro vectors following the manufacturer’s protocol exactly. Samples were stored
at -20°C.
Incorporating the Mutant Proline tRNA into the phiKZ Genome
Several strategies for restriction digest of whole wild type phiKZ genomes and SuperPro vectors
were developed which would allow the removal of the wild type phiKZ proline tRNA in one
restriction fragment. This would then permit a matching restriction fragment containing the
SuperPro mutant proline tRNA to be ligated into the phiKZ genome in its place. Restriction
enzyme digest sites within the phiKZ genome were identified using the NEBcutter tool (Vincze
et al. 2003).
Initial restriction digest designs aimed to functionally shred the phiKZ genome, breaking
it into fifteen to twenty pieces using groups of five or more restriction enzyme types in order to
generate fragment sizes near or below 20 Kbp, allowing them to be resolved by standard agarose
gel electrophoresis which can resolve fragments up to approximately 20 Kbp in size. Challenges
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presented by full digest with multiple restriction enzymes coupled with the necessity to
accurately ligate together tens of fragments motivated pursuit of an alternative restriction design.
Restriction digest designs targeted to the region of the phiKZ genome containing its
tRNAs were considered the best methods by which the wild type and mutant proline tRNAs
might by exchanged using a restriction digest and ligation approach. The two targeted digest
designs begin with the digestion of the phiKZ genome with its only two-cutter restriction
enzyme, SgsI, splitting the genome into a 54,258 bp fragmenting containing the phage tRNAs
and a 226,076 bp fragment. Mutant SuperPro vectors would also be digested with SgsI, opening
an SgsI site at the left end of the phiKZFUNK insert. The two phiKZ genome fragments would
then be separated from each other and purified using pulsed field gel electrophoresis (PFGE).
The ~54 Kbp fragment would then be further digested by one of the following two methods to
allow insertion of the SuperPro mutant genome section.
One targeted method to achieve SuperPro insertion involved digestion of the ~54 Kbp
genome fragment and SgsI digested SuperPro vectors with SphI, opening a restriction site at the
right end of the phiKZFUNK insert, allowing separation of the mutant inserts from their pUC19
vectors. Following SphI digest, the ~54 Kbp fragment would be broken into six restriction
fragments ranging in size from 2,488 bp to 17,244 bp. Digestion at the SphI site furthest left in
the ~54 Kbp fragment produces a 2,488 bp restriction fragment which would be removed and
replaced with purified SgsI/SphI digested SuperPro mutant segments. All other fragments would
be kept and used to ligate the phiKZ genome back together.
The second targeted method for SuperPro insertion involved serial digestion of the ~54
Kbp genome section with restriction enzymes KasI, BsiWI and MfeI. The genome fragment
would first be digested with KasI and the resulting 28,303 bp and 25,955 bp fragments would be
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separated by PFGE. The purified 28,303 bp fragment would then be digested with BsiWI and the
resulting 4,245 bp and 24,058 bp fragments would then be separated by gel electrophoresis.
Finally, the purified 4,245 bp fragment would be digested with MfeI, producing 2,120 bp and
2,715 bp fragments to be separated by agarose gel electrophoresis. The 2,120 bp fragment would
be discarded and replaced with SgsI/MfeI double digested SuperPro mutant fragments.
Remaining fragments would be used to ligate the phiKZ genome back together.
While the aforementioned methods were attempted, this strategy was abandoned due to
complications in working with the phage that could not be overcome. Further discussion of this
strategy is included in Chapter Four. An effective strategy to replace the wild type proline tRNA
of phiKZ with the SuperPro mutant tRNA was not identified that could be used to finish
engineering this mutant phage strain.
Strategy II: Duplicating a Subset of phiKZ tRNAs
PCR Amplification of the Genomic Region to be Duplicated
In order duplicate a region of the phiKZ genome containing three of its six tRNAs (those
for aspartic acid, methionine and proline), a 1,604 bp section of this region (genome location
271,799-273,403 bp), hereafter referred to as Looper, was identified. Primers used to amplify
Looper were designed using Primer3 (Koressar & Remm 2007, Untergasser et al. 2012).
Forward primer 5’-CGACTGAGCTATCACGGAAT-3’ and reverse primer 5’GGGGGCGCGCCAATCTTCCGGCTACGGTCTT-3’ were designed. The reverse primer
includes an added restriction site for SgsI (5’-GGCGCGCC-3’), underlined in the primer
sequence. An additional SgsI site occurs naturally at the left end of the Looper sequence. SgsI
sites flanking Looper amplicons allow Looper duplicates to be inserted into the phiKZ genome
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via the SgsI site in the Looper amplicon sequence. Primers were synthesized by Eurofins
(Huntsville, AL).
Looper PCR reactions consisted of 5 μl 10x Invitrogen PCR buffer, 0.5 μl 100 mM
dNTPs, 1 μl 100 μM forward primer, 1 μl 100 μM reverse primer, 1.5 μl 50 mM MgCl2, 1 μl
template phiKZ DNA (minimum concentration 100 μg/ml), 0.2 μl 2 U/μl Invitrogen Platinum
Taq Polymerase, and 35.5 μl nuclease-free water.
Looper amplicons were generated using the following thermalcycling conditions: 98°C 5
min, 40 cycles of: 98°C 1 min, 62.7°C 1 min, 72°C 4 min, and 72°C for 10 min. Two negative
controls using nuclease-free water and P. aeruginosa DNA in place of the phiKZ DNA template
were run using the same thermalcycling conditions.
Looper amplicons were confirmed by running PCR products through a 1.2% agarose gel
at 90 V for 45 min. Single bands of the expected ~1,600 bp size confirmed Looper amplification.
Confirmed Looper PCR products were purified using the EZNA Cycle Pure Spin kit (Omega
Bio-tek, Norcross, GA), following the manufacturer’s protocol exactly, using only 30 μl of
elution buffer in the final protocol step to increase DNA yield.
SgsI Digest and Ligation of phiKZ Genomic DNA and Looper
phiKZ DNA (minimum concentration 100 μg/ml) and Looper (minimum concentration
100 μg/ml) were each digested with Thermo Fisher Scientific (Waltham, MA) Fast Digest SgsI
following the manufacturer’s plasmid DNA digest protocol. The 20 μl digest solution consisted
of 2 μl 10x Fast Digest Buffer, 2 μl of either phiKZ or Looper DNA (each with a minimum
concentration of 100 μg/ml), 1 μl 10 U/μl SgsI, and 15 μl nuclease-free water. The digest
solution was mixed and then incubated at 37°C for 10 min. SgsI enzymes were heat deactivated
at 65°C for 20 min.
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SgsI digested phiKZ genomes and Looper amplicons were ligated together to generate
putative mutant phage genomes in solutions consisting of 2 μl Fermentas (Waltham, MA) T4
Ligase Buffer, 1 μl 4U/μl Fermentas T4 DNA ligase, 1 μl SgsI digested Looper (489 μg/ml), 5 μl
SgsI digested genomic phiKZ DNA (10.1 μg/ml), and nuclease-free water to a 20 μl volume.
Ligation solutions were mixed and incubated at 25°C for 1 h. The ligase was then heat
inactivated at 60°C for 10 min. Solutions were chilled on ice for 5 min then stored at -20°C.
Transformation of Looper/phiKZ Genome Ligation Products into Spheroplasts
Chemically competent P. aeruginosa cells (spheroplasts) were made following the
protocols of Benzinger et al. (1971) utilizing P. aeruginosa grown in LB broth for 18 h at 37°C,
shaking at 125 rpm. Spheroplasts were stored at -20°C prior to use.
Putative mutant phage genomes were transformed into these P. aeruginosa spheroplasts
by the following procedure: (1) 5 μl Looper/phiKZ genome ligation product was added to 50 μl
gently thawed P. aeruginosa spheroplasts on ice; (2) spheroplasts were rested on ice for 30 min;
(3) cells were heat shocked in a 42°C water bath for 30 s and immediately placed back on ice for
2 minutes; and (4) transformed spheroplasts were placed in 500 μl of prewarmed 37°C SOC
media and incubated for 3 h at 37°C, shaking at 120 rpm. One set of transformants was
refrigerated at 4°C after the initial 3 h growth period and a second set grew an additional 15 h.
Putative mutant phage was extracted by lysing spheroplasts in a 1:10 solution of
transformed spheroplast culture with 1% saline. The resulting lysate was then spotted onto P.
aeruginosa bacterial lawns in 5 μl increments and allowed to dry. Lawns were grown for 18 h at
37°C. Resulting plaques were harvested by the methods described previously for harvest of wild
type phiKZ. Phage lysate was then diluted by 10x dilution series from 10 1 to 105 and spotted
onto lawns to resolve individual plaques. Forty individual plaques were isolated from these
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lawns and placed in separate microcentrifuge tubes filled with 1.5 ml 0.8% saline. Tubes were
flatbed vortexed for 10 min followed by centrifugation at 10000 g for 30 s. The resulting lysate
was transferred to a new microcentrifuge tube then 5 μl of 10% chloroform was added. Tubes
were vortexed 5 s to lyse any remaining host cells. 100 μl lysate was added to 1 ml turbid P.
aeruginosa culture (24 h growth) in a microcentrifuge tube and incubated at 37°C, shaking at
125 rpm. After 18 h, 10 μl of 10% chloroform was added to each phage culture followed by a 5 s
vortex. 250 μl of the resulting lysate was used for DNA extraction following the exact method
used to extract wild type phiKZ DNA (including additional heating), as previously described.
Confirmation of the Looper Duplication by PCR
Mutant phage populations containing the desired Looper duplication were confirmed by
PCR using a series of primers targeted to the specific architecture of a single Looper insertion in
the phiKZ genome. Five total primers pairs were designed, two positive control primer pairs
confirming the presence of phiKZ DNA and three pairs which confirmed the presence of the
desired mutation. All primers were designed using Primer3 (Koressar & Remm 2007,
Untergasser et al. 2012) and were synthesized by Eurofins (Huntsville, AL).
One control primer pair targeted phiKZ’s methionine tRNA and the second targeted a
phiKZ capsid protein, ORF 27. The tRNA control primers were pkzTRNA-L with sequence 5’ACATCCTCGCCGATAAGTTC-3’ and pkzTRNA-R with sequence 5’TACGGAGTGTAGCGCAGTTG-3’, with an expected amplicon size of 954 bp. The ORF 27
control primers were pkzControl-L with sequence 5’-CACGCGTGTAATCAAGACC-3’and
pkzControl-R with sequence 5’-CCTACTCGTTGGCCAAGTC-3’, with an expected 964 bp
amplicon size.
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Primers confirming the Looper duplication were designed utilizing the sequence of the
region of the phiKZ genome containing the Looper sequence duplicate manually inserted at the
SgsI site sequence. Confirmation primers targeted the joint sequence between the normal
genome and the repeated Looper sequence. Three confirmation primer sets were designed and
each functioned such that the forward and reverse primers would only generate amplicons if the
desired duplication was present. If the Looper duplication were not present, the forward primer
would hybridize upstream of the reverse primer and no amplification would occur.
The three sets of confirmation primers were as follows: Set 1 consisted of forward primer
pkzDup1-L* with sequence 5’-CAACTGCGCTACACTCCG-3’ and reverse primer pkzDup1-R
with sequence 5’-GAACTTATCGGCGAGGATG-3’ (expected amplicon size 680 bp), Set 2
consisted of forward primer pkzDup1-L* with sequence 5’-CAACTGCGCTACACTCCG-3’ and
reverse primer pkzDup1.2-R with sequence 5’-CACCTGACCGATGAAGTAACC-3’ (expected
amplicon size 761 bp), and Set 3 consisted of forward primer pkzDup2-L with sequence 5’GAACTTATCGGCGAGGATG-3’ and reverse primer pkzDup2-R with sequence 5’GCCATGTGGATAGGTTACAG-3’ (expected amplicon size 947 bp).
Control and confirmation primers were first tested using wild type phiKZ DNA. 50 μl
PCR solutions for each primer pair consisted of 25 μl Amresco (Solon, OH) 2x Ready PCR Mix,
1 μl 100 μM forward primer, 1 μl 100 μM reverse primer, 1 μl phiKZ DNA (100 μg/ml
minimum), and 22 μl nuclease-free water.
PCR was carried out using the following thermalcycling conditions: 95°C 2 min, 30
cycles of: 95°C 30 s, 55°C 30 s, and 68°C 1 min, with a final extension at 84°C for 7 min.
Negative control PCRs utilizing nuclease-free water or P. aeruginosa DNA in place of phiKZ
DNA were run using the same thermalcycling conditions.
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PCR products were visualized by running products through a 1.2% agarose gel with
ethidium bromide at 90 V for 30 min. Amplicons of the expected lengths appeared as bright
bands for both control primer sets and no bands appeared for reactions using the three
confirmation primer sets. No amplification was observed for any of the negative controls for any
of the five primer pairs.
The same PCR reaction mixes and thermalcycling conditions described to test the control
and confirmation primer pairs on ancestral phiKZ DNA were prepared and used to test for the
presence of the Looper duplication in the DNA extracted from 40 isolated mutant phage plaques.
Twenty-five of the 40 isolates were tested before the Looper mutant was successfully confirmed
via PCR. Negative control PCRs using nuclease-free water or P. aeruginosa DNA in place of
phage DNA were also run utilizing the same thermalcycling conditions.
Putative mutant phage DNA sample B1 produced amplicons of the expected size for both
control primers and confirmation primers sets 1 and 3 (primer set 2 produced no amplicon), as
visualized through a 1.2% agarose gel. PCR was run on B1 DNA again twice (prepared and run
separately) using the same PCR solution and thermalcycling conditions along with negative
controls (Figure 5). Primer set 2 consistently failed to produce an amplicon and thus may not be
a compatible primer pair. Phage B1 belonged to the phage group isolated from spheroplasts
grown for only 3 h in SOC media following heat shock transformation, rather than those grown
for 18 h (methods described previously).
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Figure 5. Agarose gel confirmation of B1 mutant for the duplication insertion within the tRNA
cassette of phiKZ.
Propagation of Engineered phiKZ
In order to track the evolution of codon usage in phage B1, multiple lineages were
serially transferred through naïve P. aeruginosa cultures. Prior to beginning propagation,
ancestral phiKZ and B1 phage populations were titered. Each phage was serially diluted in a
series of 12 PCR tubes containing 100 μl each of 0.8% saline. 10 μl of stock phage lysate was
added to the first tube and mixed by pipetting, then 10 μl of the first dilution was added to the
second tube and mixed by pipetting, and this process was repeated for the following ten tubes. 10
μl of each dilution was spotted onto P. aeruginosa lawns then allowed to dry. These lawns vary
slightly from those described previously: 1 ml turbid P. aeruginosa liquid culture was added to 3
ml warm liquid LB SA and was spread evenly by oscillating the LB plate, creating a higher
density lawn. Plates were incubated for 18 h at 37°C. Higher degree dilutions allowed individual
plaques to be counted to quantify the number of Plaque Forming Units (PFU) in each phage
stock solution.
P. aeruginosa grown for 24 h was also titered using the previously described dilution
series. Each dilution was spread entirely over separate LB plates using a cooled, flame sterilized
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bacterial spreader. Plates were incubated for 18 h at 37°C. Higher level dilutions allowed
individual colonies to be counted in order to quantify the number of Colony Forming Units
(CFU) in P. aeruginosa stock after 24 h growth.
Six B1 lineages were serially transferred five times by the following procedure: 1) each
B1 lineage was started by inoculating 3 ml P. aeruginosa liquid LB culture (~109 CFU/ml) with
100 μl of B1 phage (~106 PFU/ml) for an initial multiplicity of infection (MOI) less than 0.1; 2)
phage cultures were grown at 37°C, shaking at 130 rpm for 2.25 h; 3) phage cultures were then
vortexed with 20 μl of 10% chloroform in order to lyse the host cells; and 4) 1 ml of the resulting
lysate was then inoculated into 3 ml of naïve ~109 CFU/ml P. aeruginosa liquid culture and
grown for 2.25 h at 37°C, shaking at 130 rpm. Steps 2-4 were repeated three more times.
Alongside the B1 lineages, two control lines of ancestral phiKZ phage were serially transferred
by the same procedure used for B1, starting with a phage concentration of ~10 5 PFU/ml. Uninoculated P. aeruginosa was grown alongside each of the experimental lines as a negative
control. Remaining lysate from each transfer of both B1 and wild type phiKZ was serially diluted
via a 10x dilution series for 101 to 108 and spotted onto higher-density P. aeruginosa lawns in 10
μl increments. Dilutions were used to titer the resulting lysate and ensure that phage was still
present after each transfer. All remaining lysate not used to inoculate bacteria or in dilution series
was stored at 4°C.
Sequencing the Evolved Engineered phiKZ Lines
From the dilution series for each line after 5 transfers, six individual plaques were picked
up using a micropipette tip and placed into a microcentrifuge tube filled with 700 μl 0.8% saline.
This included six individual plaques from each of the six evolved B1 lines and each of the two
evolved phiKZ ancestral control lines.
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Tubes were vortexed for 10 min to release plaques from the SA into solution. 700 μl
turbid P. aeruginosa (24 h growth) was then added to each tube. All tubes were incubated for 6-7
h at 37°C, shaking at 120 rpm. 250 μl of each phage culture was then place in a microcentrifuge
tube, 10 μl of 10% chloroform was added and tubes were vortexed for 5 s. The remaining phage
culture was placed back in the incubator to continue growth for a full 24 h. Phage DNA was
extracted from the 250 μl samples of phage lysate by the same procedure used to isolate wild
type phiKZ as described previously. Successful DNA extraction was confirmed by running DNA
through a 1.2% agarose gel at 90 V for 40 min.
In order to examine the effects of the engineered duplication on phage codon usage, a set
of 22 genes was identified for direct sequencing. Genes of interest were selected based on their
status as either structural genes or as genes with RSCU values below 1 for codons recognized by
phiKZ’s aspartic acid and proline tRNAs. These genes were expected to be among the most
likely candidate genes to reflect any changes in codon usage resulting from changed self-tRNA
abundance produced by the Looper duplication. Twenty primers were designed to PCR amplify
these genes of interest. All primers were designed using Primer3 (Koressar & Remm 2007,
Untergasser et al. 2012) and were designed to generate similar amplicon lengths (~1,000 bp) and
have compatible melting temperatures, allowing PCR with all or most primers to be run using the
same thermalcycling conditions. Primer sequences and their expected amplicon sizes are listed in
Table 2. Primers were synthesized by Eurofins (Huntsville, AL).
Gene
026
028
032

Primer Name
Orf026-L
Orf026-R
Orf028-L
Orf028-R
Orf032-L

Genome Loc.
14932-14949
15974-15991
19298-19315
20298-20316
25303-25323

Ampl. Size
1059
1018
1074

Primer Sequence (5'-3')
TCACGACGAATCCAGGTG
TGCAGAATGGTGAACGTG
TTGCATCGTCAGAACGTG
TGGAGCTTTGAACTCGATG
CCAGTCCTAGTTGCTGCGATA
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Gene

Primer Name
Genome Loc.
Ampl. Size
Primer Sequence (5'-3')
Orf032-R
26358-26377
GGAATGCTGATCACTCTGCT
035
Orf035_L
28309-28330
948
CATTATCCAGATTGGTGTATCG
Orf035-R
29238-29257
GTTGCTTCACTTGCACCTTC
052
Orf052-L
43836-43854
1010
CAACTTGTGCCTGTTGAGC
Orf052-R
44826-44846
AGGTGGTTGATCCTAACATCC
083
Orf083-L
80465-80483
1033
ATCCATCGTGCTAATCGTG
Orf083-R
81481-81498
GGTGCCACATCAGAATGG
084
Orf084-L
82012-82031
1013
AGCGTGACTTAGGTCCATTG
Orf084-R
83005-83025
TGTCATCATCAATTCCTGGTT
086
Orf086-L
83743-83760
1056
TGGTTGAAGGCGAAGAAG
Orf086-R
84778-84799
GCTGCTAGATATTGTGCTTGAG
106Orf106-7-L 108233-108251
1084
TGATAGCAGTGGCGAAGAG
107*
Orf106-7-R 109300-109317
GGTACCAGCCAGCATGAG
110Orf110-11-L 111285-111303
581
CTGGCAGACTGGCTATGTG
111
Orf110-11-R 111847-111866
ATACCCCTTGCACCGATCAA
120
Orf120-1-L 118380-118400
1043
ACAGCGTTGTTAGTCAAGGTC
Orf120-1-R 119408-119423
CGCCATCAGCTGAACC
Orf120-2-L 119257-119274
1317
CGTTCTACTCGGCGGTAA
Orf120-2-R 120557-120574
GGCATTACCGTCTTCCAA
121Orf121-22-L 120842-120862
1118
TGAAGAATTCCATCCTGTTCA
122* Orf121-22-R 121943-121960
CAACCATTGCAGCAGCTT
145
Orf145-1-L 147369-147386
1110
GCAGCTGGTCAAGTCGAT
Orf145-1-R 148461-148479
CTAACGGATAACCGCCAGT
Orf145-2-L 148380-148398
1182
GTTGTAGAACACGCCGATG
Orf145-2-R 149546-149562
TGCCATCCTTGATGGTG
177
Orf177-L
180657-180674
924
TGAGGTGCAACATCACCA
Orf177-R
181564-181581
TTGTTGGCTCAGCACGTA
183
Orf183-L
197845-197867
928
TGGTGTAGGTCTAGCATTAACTG
Orf183-R
198753-198773
TGCATAGTTACCCATCCACCA
198
Orf198-L
206204-206225
945
CAATTGCTCATTGCATTATTGA
Orf198-R
207130-207149
TTCACAACGTCGATCTTCAC
209
Orf209-L
216756-216773
1093
AACAAGCGATTGCAGCTC
Orf209-R
217832-217849
GAATAGCGCTGGTGGATG
217Orf217-18-L 221152-221171
1019
GGTCTTGAGCTATTCGGTTG
218* Orf217-18-R 222154-222171
CCACCACCAACATTAGGC
Table 2. Primer pairs used to amplify phiKZ genes of interest for sequencing. Left primers are
marked L and right primers are marked R. *Primer sets that did not amplify ancestral phiKZ
DNA.
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These 20 sequencing primers were tested using ancestral phiKZ DNA. Each PCR
solution consisted of 25 μl Amresco (Solon, OH) 2x PCR Ready Mix, 0.5 μl 100 μM forward
primer (indicated by “L” in the primer name), 0.5 μl 100 μM reverse primer (indicated by “R” in
the primer name), 1 μl phage DNA, and 22 μl nuclease-free water.
All PCRs were run using the following thermalcycling conditions: 95°C for 10 min, 40
cycles of: 95° for 30 s, 54°C for 30 s, and 68°C for 1 min 20 s, and a final extension at 68°C for
5 min. Negative controls using nuclease-free water in place of DNA were run using the same
thermalcycling conditions. Amplification was confirmed by running 5 μl of each PCR product
through a 1.2% agarose gel. Three of the primer pairs designed (indicated in Table 2 by
asterisks) did not produce amplicons and were thus removed from the set.
Primer sets 120-1 and 145-1 were used to identify three DNA samples from each lineage
that contained phage DNA with sufficiently high concentration to run PCR for all other primer
sets. PCR utilizing the remaining 15 primer pairs (17 pairs total per isolate covering 16 genes of
interest) were run following the same reaction mix and thermalcycling conditions used for the
control phiKZ DNA. Negative controls using nuclease-free water and positive controls using
ancestral phiKZ DNA in place of experimental DNA were also run using the same
thermalcycling conditions.
Amplification of the desired PCR products was confirmed by running all products
through a 1.2% agarose gel. Confirmed PCR products were purified using an EZNA (Omega
Bio-tek, Norcross, GA) Cycle Pure Spin Kit following the manufacturer’s protocol exactly, using
only 30 μl of elution buffer in the final protocol step to boost DNA yield.
Sanger sequencing was performed on all purified PCR samples obtained from one of the
replicate B1 lineages. Sequencing was conducted by GeneWiz (South Plainfield, NJ).
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Sequence Analysis
All sequences were aligned against the ancestral phiKZ genome sequence using Geneious
version 10.0.09 (available at http://www.geneious.com/) to identify mutations.

CHAPTER THREE
CODON USAGE ANALYSIS: RESULTS & DISCUSSION
Codon Usage Analysis of phiKZ
The overall Relative Synonymous Codon Usage (RSCU) values were calculated for the 258
phiKZ genes selected for analysis (listed in Appendix A). These values are listed in Table 3.
RSCU values are calculated as the ratio of observed codon usage to expected codon usage where
RSCU values greater than 1 are indicative of codons that are used more often than expected
(Sharp & Li 1987). Twenty-six of the codons within the phiKZ genes have RSCU values greater
than one, all of which have A or U at their third position. This bias toward codons with A or U at
the third position reflects the overall AT enrichment of the phiKZ genome (%GC = 36.8).
The codon usage of P. aeruginosa has previously been found to be shaped by weak
translational selection. Although it is not as strongly translationally biased as other bacterial
species, e.g. E. coli, there is evidence of selection for translational efficiency via the use of more
abundant tRNAs within the coding sequences of highly expressed genes (HEGs) (Sharp et al.
2005). Thus correspondence between phiKZ and P. aeruginosa’s codon usage is expected if the
phage’s codon usage is under selection for translational efficiency. phiKZ’s codon usage
correspondence with its host appears to be weak, however. None of phiKZ’s overrepresented
codons are also overrepresented in the overall host genome based on RSCU values previously
calculated for the overall P. aeruginosa genome (Grocock & Sharp 2002) and only four of
phiKZ’s overrepresented codons are overrepresented among P. aeruginosa’s HEGs. Notably, the
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four codons overrepresented in both phiKZ and P. aeruginosa’s HEGs are the only A or U
ending codons overrepresented in P. aeruginosa’s HEGs (indicated by ‘**’), suggesting that this
correspondence may be an artifact of phiKZ’s.
AA
Phe

Codon N
RSCU AA Codon N
RSCU
UUU
1706 1.17
Ser UCU
1166 1.58
UUC
1218 0.83
UCC
287 0.39
Leu UUA
2099 2.08
UCA
1202 1.63
UUG
412 0.41
UCG
205 0.28
CUU
1148 1.14
Pro CCU
1054 1.42
CUC
300 0.3
CCC
191 0.26
CUA
1685 1.67
CCA
1397 1.88
CUG
400 0.4
CCG
337 0.45
Ile
AUU
3099 1.77
Thr ACU
2281 1.98
AUC
1432 0.82
ACC
715 0.62
AUA
714 0.41
ACA
1331 1.15
Met AUG
1939 1
ACG
292 0.25
Val GUU
2189 1.75
Ala GCU** 2068 1.82
GUC
406 0.32
GCC
479 0.42
GUA
1901 1.52
GCA
1665 1.46
GUG
515 0.41
GCG
335 0.29
Tyr UAU
2371 1.52
Cys UGU
487 1.43
UAC
751 0.48
UGC
194 0.57
TER UAA
174 2.02
TER UGA
56
0.65
UAG
28
0.33
Trp UGG
942 1
His CAU
1085 1.52
Arg CGU** 1517 2.64
CAC
341 0.48
CGC
365 0.63
Gln CAA
1737 1.37
CGA
490 0.85
CAG
791 0.63
CGG
245 0.43
Asn AAU
3268 1.47
AGA
476 0.83
AAC
1187 0.53
AGG
358 0.62
Lys AAA
3186 1.39
Ser AGU
1209 1.64
AAG
1397 0.61
AGC
359 0.49
Asp GAU
4062 1.64
Gly GGU** 2687 2.58
GAC
895 0.36
GGC
544 0.52
Glu GAA** 3484 1.52
GGA
636 0.61
GAG
1114 0.48
GGG
305 0.29
Table 3. Pooled RSCU values and codon counts for the 258 phiKZ genes analyzed. AA indicates
the encoded amino acid. N is the number of occurrences of the codon across all examined genes.
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Codon Usage Variation Among phiKZ Genes
To analyze the codon usage variation among individual phiKZ genes, N c and GC3 values were
calculated for each of the genes analyzed. Nc values ranged from 32.22, with a mean value of
43.85 (standard deviation 5.06). Low Nc values, Nc < 40, indicate strong codon usage bias while
higher Nc values indicate weak or no codon usage bias (D’Andrea et al. 2011). Only 47 (18.2%)
of the phiKZ genes analyzed demonstrated Nc values below 40 and none demonstrated extreme
codon usage bias (Nc < 30). Thus, phiKZ does not demonstrate strong codon usage bias overall.
The wide range and high standard deviation of phiKZ’s Nc values demonstrates substantial
variation in the level of codon usage bias among individual genes. GC 3 values of phiKZ ranged
from 0.12-0.492 with a mean value of 0.237 (standard deviation 0.063). The phiKZ genes
analyzed demonstrated a maximum GC content at their third codon positions below 50%, with
181 of the 258 genes (70%) having GC3 values below 0.25. These GC3 values further
demonstrate that phiKZ has a strong preference for A and U ending codons.
The Nc and GC3 values of the phiKZ genes were plotted against each other to further
examine the variation in codon usage among the sequence set analyzed (Wright 1990). phiKZ’s
Nc versus GC3 plot, shown in Figure 6, is superimposed over a bell curve representing the
expected Nc values if codon usage were solely determined by GC3 values, in which case codon
usage is random and determined by genomic composition. Most phiKZ genes fall to the GC poor
end of the plot as is expected for this GC poor gene set. Genes whose plot points deviate from
(either falling above or below) the expected Nc versus GC3 curve demonstrate codon usage
biases shaped by factors beyond compositional constraint, most likely translational selection.
Figure 6 shows that the majority of phiKZ genes fall on or near the expected curve, indicating
that the majority of these genes’ codon usage is primarily the result of compositional constraint.
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Figure 6. Plot of Nc versus GC3 values for phiKZ genes. The continuous curve represents the
expected Nc distribution given no selection (random codon usage).
A subset of genes fall above or far below the expected Nc versus GC3 curve, indicating
that these genes may be subject to stronger translational selection than those genes that fall on or
near the expected curve. Genes with Nc values greater than expected and those outlying genes
with Nc >10 below the expected value for their GC3 content are considered likely to demonstrate
codon usage determined more by translational selection than compositional constraint (Wright
1990, Peden 1999). Those genes with codon usage that appears to be translationally selected
based on their relationship to the expected Nc distribution are listed in Table 4 along with their
predicted functions. Notably, while it is expected that structural phage genes experience greater
translational selection than non-structural genes due to both their expected high expression levels
and conservation (Carbone 2008), only 6 of the 44 genes identified in Table 4 are known
structural genes so the deviation from compositional constraint observed among these genes may
result from factors outside both composition and translational selection.
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Observed v. Expected Nc value
Nc value >10 below expected for GC3

Gene
10
14
15
54
55
61
71

Nc value greater than expected for GC3

110
111
115
217
218
263
31
53
62
79
81
96
102
132
137
140
141
171
181
183
194
198
207
209
210
224
234
243
253
265
267
269
275
276

Predicted function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Major non-virion RNA polymerase
protein
Predicted protein
Minor non-virion RNA polymerase
protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Capsid protein
Predicted protein
Capsid protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
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289
Predicted protein
298
Tail protein
302
Predicted protein
Table 4. phiKZ genes with Nc values indicating codon usage selection outside of compositional
constraint. Structural genes and their predicted functions are shown in bold.
Correspondence Analysis of phiKZ Codon Usage
Correspondence analysis (COA) is a multivariate statistical technique frequently used to identify
how the degree of codon usage bias varies among sets of genes. COA simplifies high
dimensional data, like codon usage data, by reducing the data down to a more interpretable, low
dimensional set demonstrating the relationships between the original data points (Suzuki et al.
2008). When analyzing codon usage, COA plots codon usage data along 59 axes corresponding
to all sense codons with synonyms (termination codons and codons without synonyms, those for
methionine and tryptophan, are excluded from analysis), to identify how codon usage varies
among individual genes. The relationships among genes based on their codon usage identified
from the initial 59 dimensional plot are then consolidated down to four major axes of variation.
The first axis accounts for the most variation among the genes’ codon usage, while each
subsequent axis accounts for less and less variation. Gene sets whose first axis of variation
accounts for twice as much or more variation than the second axis demonstrate substantial
differences in the codon usage biases observed among individual genes and are expected to
demonstrate strong translational selection for their codon usage (Peden 1999).
COA enables identification of the groups of genes within a set with the most and least
biased codon usage. In species for which gene expression levels are known the relationship
between genes’ level of codon usage bias and expression level can be gauged. If codon usage
bias is found to positively correlate with gene expression levels, then a preferred set of codons
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for the genes analyzed can be calculated based on the differences in codon usage between the
high and low bias gene sets identified by COA.
COA was performed for both codon count (CCOA) and RSCU values (RCOA) of phiKZ
genes in order to compare results between the two and to correct for any distortion yielded by
either analysis alone (Peden 1999, Perrière & Thiolouse 2002). RCOA is often preferred over
CCOA for codon usage analyses because the variation among genes observed for codon counts
may also reflect differences in genes’ amino acid compositions and lengths. CCOA is most
confounded by genes whose products are highly hydrophobic (GRAVY > 0.3), which are found
to cluster together along the axes of variation apart from other genes. RCOA bypasses this issue
with CCOA as RSCU values normalize the codon usage of genes for both amino acid
composition and length. However, RCOA can also result in skewed codon usage comparisons. In
RCOA, codons that do not appear in a gene are automatically corrected to have a non-zero
RSCU value by assigning the absent codon a relative frequency of one over the number of
synonymous codons available for its amino acid, causing a distortion in the axes positions of
genes with absent codons (Perrière & Thioulouse 2002). This distortion primarily becomes a
problem when the set of genes analyzed has an overall deficiency for one or more codon types,
usually commonly rare amino acids like cysteine, skewing the positions of all codon deficient
genes in the set. Performing both CCOA and RCOA then comparing their results is especially
important when analyzing phage genomes as many phage genes, based solely on their small size,
do not contain all codons, potentially causing data distortion for either CCOA or RCOA
depending on the genome’s overall codon distribution.
A plot of phiKZ gene positions on the first and second major axes of variation for CCOA
is shown in Figure 7 and the same plot for RCOA is shown in Figure 8.
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Figure 7. Plot of phiKZ genes along the first two major axes of variation for CCOA. Structural
genes are shown in orange and non-structural genes are shown in blue.

Figure 8. Plot of phiKZ genes along the first two major axes of variation for RCOA. Structural
genes are shown in orange and non-structural genes are shown in blue.
CCOA and RCOA axis 1 values are found to be strongly negatively correlated with each
other (R = -0.899, p<0.01), indicating that gene positions on the axes of variation for both COA
types are highly similar and analysis of codon usage bias of genes based on either of these
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analyses will provide similar results. As is expected for CCOA and RCOA of the same sequence
set, gene positions on a given axis are mirrored between the two analyses. Cysteine codons are
rare in this gene set (N < 700) with 38 genes (14.7%) having no cysteine codons at all, which is
expected to cause a marked distortion in the axis positions calculated by RCOA for genes
deficient in cysteine. Only 3 genes in this set have high GRAVY scores (GRAVY > 0.3), so
amino acid composition effects on CCOA are expected to be minimal. Thus, for purposes of this
analysis, CCOA will be used to assess the variation in codon usage bias among genes.
CCOA axis 1 accounts for 12.5% of the total variation observed for this data set and axis
2 accounts for 7% of the observed total variation. Axis 1 accounts for less than twice the amount
of codon usage variation observed compared to axis 2, indicating that any translational selection
experienced by this gene set is moderate or weak. Axis 1 accounts for less total variation both
overall and in comparison to axis 2 than is typically observed for genomes under strong
translational selection (Peden 1999). The genes of phiKZ are spread broadly across CCOA axis 1
and demonstrate minimal clustering to either the positive or negative ends of the axis indicating
that the individual codon usage patterns of these genes vary substantially. Structural genes,
shown in orange, demonstrate a similar pattern of spread about both axis 1 and axis 2 as nonstructural genes, shown in blue, indicating that degree of codon usage bias varies as much among
structural genes as it does among non-structural genes.
The orientation of genes on axis 1 is arbitrary. Genes demonstrating strong codon usage
bias will fall to one end of axis 1, while genes with the least biased codon usage will fall to the
other end. The average Nc values of the 20% (N=51) of genes farthest left and the 20% of genes
farthest right on axis 1 were compared to determine which end of axis 1 demonstrates greater
codon usage bias. Lower Nc values indicate higher levels of codon usage bias. The genes lying to
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the right of axis 1 with an average Nc of 42.64 are observed to have greater levels of codon usage
bias than those to the far left of axis 1 with an average N c value of 47.51.
The 20% of genes located on the far right of axis 1 include those phiKZ structural genes
which are expected to be present in the greatest copy number in each virion including the major
and minor capsid proteins (the first and second most abundant proteins of each virion), the tail
sheath protein, and the more abundant inner body proteins. The orientation of these high copy
number, putatively highly expressed genes on the end of axis 1 associated with greater codon
usage bias may indicate that degree of codon usage bias corresponds with gene expression level
in phiKZ. However, as the gene expression profile of phiKZ is not known, no definitive
conclusions can be drawn about the relationship between codon usage bias and gene expression
level.
Gene positions on axis 1 demonstrated no significant correlation with T 3, G3, or C3
values. Axis 1 gene position was found to positively correlate with GC 3 (R=0.563, p<0.01) and
negatively correlate with A3 (R=-0.703, p<0.01). These results identify a moderate trend toward
greater numbers of G and C ending codons among genes to the right of axis 1 and a strong trend
toward enrichment with A ending codons to the left of axis 1. A greater incidence of G and C
ending codons among genes to the right of axis 1 where codon usage bias is strongest indicates
that the codon usage of these genes corresponds to a greater degree with host codon usage and
thus may be subject to stronger translational selection than other phiKZ genes. Absence of axis 1
correlation with T3, G3, C3 and only a moderate correlation with GC3 all point toward substantial
compositional similarity among phiKZ’s genes. Overall, phiKZ’s codon usage appears to
primarily result from strong compositional constraint to maintain a highly AT enriched genome.
While translational selection appears to weakly influence codon usage among phiKZ’s high bias
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gene set and may account for the deviation from compositional constraint observed for those
genes listed in Table 4, the effects of translational selection are either weak or confounded by
compositional effects throughout the remainder of the phiKZ genome.
It is interesting to note that these findings are similar to those obtained from a previous
codon usage analysis performed on phiKZ (Sau et al. 2005), although that study examined all
306 putative phiKZ ORFs. While in this case selective analysis of a subset of genes does not
appear to have significantly altered the results obtained, great care must be taken when selecting
genes for codon usage analysis, especially in phage, if the results are to accurately reflect true
codon usage biases. As with any genome, phage contain mobile element sequences that do not
reflect the native genome composition which must be excluded from codon usage analysis
(Lafay et al. 2000). Further, phage genomes are spattered with recent, horizontally acquired
genes which do not reflect the genome’s composition as they have only been under the same
selective and mutational pressures as the native genes for a short period of evolutionary time.
Codon Usage Analysis of EL
RSCU values calculated for the 166 EL genes analyzed are listed in Table 5; a listing of these
166 EL genes can be found in Appendix B. Thirty codons are overrepresented (RSCU>1) in the
EL genome, eleven of which are A or U ending. Despite having a GC content of just under 50%,
EL demonstrates an apparent preference for G and C ending codons. Thirteen of EL’s twentynine overrepresented sense codons are also overrepresented in the overall P. aeruginosa genome.
Seven of these thirteen genes are also overrepresented among the HEGs of P. aeruginosa. In
total, seventeen of EL’s overrepresented sense codons are also overrepresented among the HEGs
of P. aeruginosa. Based on RSCU values alone, EL’s codon usage appears to correspond to a
significant extent with that of its host.
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AA
Phe

Codon
N
RSCU
AA
Codon
N
RSCU
UUU
835
0.72
Ser
UCU
407
0.76
UUC*** 1500
1.28
UCC*** 633
1.19
Leu
UUA
377
0.45
UCA
225
0.42
UUG
1243
1.48
UCG*** 556
1.04
CUU
432
0.52
Pro
CCU
779
1.26
CUC*
1012
1.21
CCC*
700
1.13
CUA
216
0.26
CCA
250
0.4
CUG*** 1753
2.09
CCG*** 743
1.2
Ile
AUU
1492
1.45
Thr
ACU
495
0.57
AUC*** 1441
1.4
ACC*** 1791
2.07
AUA
152
0.15
ACA
306
0.35
Met
AUG
1248
1
ACG
863
1
Val
GUU*
992
1.01
Ala
GCU
849
0.98
GUC** 1022
1.04
GCC*** 1051
1.22
GUA
636
0.65
GCA
463
0.54
GUG*** 1292
1.31
GCG*
1086
1.26
Tyr
UAU
797
0.77
Cys
UGU
256
1.26
UAC*** 1273
1.23
UGC
149
0.74
TER
UAA
92
1.66
TER
UGA
53
0.96
UAG
21
0.38
Trp
UGG
685
1
His
CAU
499
0.93
Arg
CGU** 925
2.03
CAC*** 576
1.07
CGC
337
0.74
Gln
CAA
1030
1.06
CGA
290
0.64
CAG
914
0.94
CGG*
868
1.9
Asn
AAU
1154
0.8
AGA
138
0.3
AAC*** 1738
1.2
AGG
181
0.4
Lys
AAA
1508
0.96
Ser
AGU*
933
1.75
AAG*** 1618
1.04
AGC
449
0.84
Asp
GAU
1770
1.1
Gly
GGU** 1498
1.58
GAC
1435
0.9
GGC
490
0.52
Glu
GAA** 2304
1.25
GGA
587
0.62
GAG
1395
0.75
GGG
1210
1.28
Table 5. RSCU values for the 166 EL genes analyzed. AA indicates amino acid and N indicates
the number of codons.
* Codons which have RSCU>1 for overall P. aeruginosa genes.
** Codons which have RSCU>1 for highly expressed P. aeruginosa genes.
*** Codons which have RSCU>1 for both overall and highly expressed P. aeruginosa genes.
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Codon Usage Variation Among EL Genes
To explore variation in codon usage among individual EL genes, N c and GC3 values were
calculated for each gene. Nc values ranged broadly from 30.66-61, with a mean value of 51.81
and standard deviation of 6.157. EL genes demonstrate a slightly wider range of N c values than
phiKZ but overall EL Nc values are similarly high. Only 9 of EL’s 166 analyzed genes have N c
values below 40, indicating that the majority of EL genes demonstrate only minor to moderate
levels of codon usage bias. There is a high standard deviation among the N c values of EL genes,
so while no EL genes demonstrate strong codon usage bias (N c < 30), the level of codon usage
bias varies substantially among individual genes.
GC3 values of EL genes ranged between 0.442-0.618 with a mean of 0.565 and a standard
deviation of 0.058. While EL’s genome has a GC content of 49.3%, on average EL appears to
favor G or C ending codons in more than 50% of cases. 142 of the 166 EL genes analyzed
(85.5%) have GC3 values exceeding 0.5. These findings follow from observations that high EL
RSCU values were predominantly associated with G and C ending codons, further indicating that
compositional constraint does not appear to be the main driving force behind EL’s codon usage.
A plot of Nc versus GC3 values for EL’s genes, shown in Figure 9, was created to further
examine the relationship between gene composition and EL’s codon usage. The N c versus GC3
plot for EL is superimposed over a curve representing the expected N c versus GC3 plot under
random codon usage allowing a comparison to be made between the observed N c values and the
expected Nc values for a given GC3 value.

58

Figure 9. Plot of Nc versus GC3 values for EL genes. The continuous curve represents the
expected Nc distribution given no selection (random codon usage).
The great majority of EL genes fall far below (Nc >10 below the expected value for a
given GC3) the expected Nc versus GC3 curve. Results of the Nc versus GC3 plot strongly indicate
that composition is not the primary determinant of EL’s codon usage. These results along with
observations from EL’s RSCU values that a substantial proportion of EL’s codon usage
corresponds to the codon usage of its host’s high expression genes indicate that EL’s codon
usage is most likely determined to a significant extent by translational selection.
Correspondence Analysis of EL Codon Usage
COA for both codon count and RSCU values was performed for the EL genes analyzed in order
to further explore trends in codon usage bias among EL genes. CCOA and RCOA results for EL
were compared to ensure that the trends in codon usage identified by COA accurately reflect the
relationships among genes’ individual codon usage and are not reflective of biases caused by
gene length, amino acid composition, or rare codons. A plot of EL genes’ positions on the first
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and second major axes of variation identified by CCOA are shown in Figure 10 and the same
plot for RCOA is shown in Figure 11.

Figure 10. Plot of EL genes along the first and second major axes of variation for CCOA.
Structural genes are shown in orange and non-structural genes are shown in blue.

Figure 11. Plot of EL genes along the first and second major axes of variation for RCOA.
Structural genes are shown in orange and non-structural genes are shown in blue.
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Axis 1 values for CCOA and RCOA were found to be strongly negatively correlated with
each other (R= -0.89, p<0.01), thus analysis of codon usage bias based on either of these
analyses will produce similar results. As was the case for phiKZ, cysteine codons are rare in the
EL genome with fewer than 450 total cysteine codons among the 166 genes analyzed. Only one
EL gene was found to have a high GRAVY score (GRAVY > 0.3). EL’s deficiency in cysteine
codons is expected to cause a marked distortion in the axis 1 and 2 positions of cysteine deficient
genes for RCOA. As the overwhelming majority of EL genes are not strongly hydrophobic,
amino acid effects on gene position for CCOA are not expected to distort the relationships
among genes. Therefore, all further exploration of the variation in codon usage bias among EL
genes are based on CCOA.
CCOA axis 1 accounts for 14.1% of the total variation observed for the codon usage
among the EL gene set while axis 2 accounts for 5.9% of the total variation observed. Axis 1
accounts for more than double the codon usage variation observed compared to axis 2, indicating
that translational selection is a significant factor influencing the variation in codon usage bias
observed (Peden 1999). While the EL genes are spread broadly across CCOA axis 1, indicating a
high degree of variation in the degree of codon usage bias observed among individual genes,
most EL genes are found to cluster on the positive end of axis 1. Structural genes are found to
have a more limited range of spread across axis 1 than non-structural genes. Non-structural genes
are found in a range of axis 1 positions from -0.6 – 0.5 while structural genes are found in a
smaller range across axis 1 covering positions -0.6 – 0.2. Thus, structural genes appear to
predominate toward the left end of axis 1.
The average Nc values of the 20% (N=33) of EL genes farthest left on axis 1 and the 20%
of genes farthest right on axis 1 were compared to determine which end of axis 1 demonstrates a
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higher average degree of codon usage bias. Those 20% of genes farthest left on axis 1 with an
average Nc value of 44.54 were found to demonstrate greater codon usage bias than those genes
farthest right on axis 1 with an average Nc of 54.66. As previously noted, EL’s structural genes
have a left leaning distribution on axis 1 compared to non-structural genes, indicating that in
EL’s case structural genes appear to demonstrate stronger codon usage bias on average than
other genes. Stronger codon usage bias is expected among structural genes as they are predicted
to be among the more highly expressed and conserved of phage genes. Notably, EL’s major and
minor capsid proteins, EL78 and EL63 respectively, are among the 20% of genes on the far left
of axis 1. As was the case for phiKZ, no information is available on the expression levels of EL
genes, however finding the putatively most highly expressed and conserved genes of phage EL
among the high bias gene set may point toward an association between degree of codon usage
bias and gene expression level. The expression profile of phage EL will need to be defined in
order to draw any definitive conclusions as to the relationship between gene expression and level
of codon usage bias.
The positions of EL genes along axis 1 were found to show no significant correlation
with G3 values. Gene positions on axis 1 were found to positively correlate with A 3 (R=0.578,
p<0.01) and T3 (R=0.334, p<0.01) and negatively correlate with C 3 (R=-0.523, p<0.01) and GC3
(R=-0.59, p<0.01). These results indicate that as genes become more highly biased in their codon
usage (falling more leftward on axis 1), they become more enriched in G and especially C ending
codons while genes demonstrating the least codon usage bias (those farthest right on axis 1) are
more enriched with A and T ending codons than other genes. High bias genes are expected to be
under stronger translational selection than other genes. The trend toward greater use of G and C
ending codons among EL’s high bias genes further substantiates prior observations that EL’s
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codon usage appears to be markedly shaped by the translational influence of its host, which
demonstrates a strong preference for G and C ending codons.
Comparison of phiKZ and EL Codon Usage
phiKZ and EL, despite sharing the same host and having apparently descended from a single
common ancestor, have dramatically different codon usage profiles, which is not unusual as
significant variability in codon usage even among more closely related phage is regularly
observed (Sahu et al. 2005). More interestingly, based on these analyses, these phage species
face very different types of selective pressure on their genome structure. phiKZ’s codon usage
primarily appears to be the result of compositional bias while EL’s codon usage appears to be
substantially influenced by host translational selection. The apparent low selective pressure to
adopt host codon usage or approximate genome composition indicate that phiKZ is at least
partially metabolically independent from its host in a way that EL is not. The level of disparity
between phage and host codon usage has been found to positively correlate with phage tRNA
copy number among Aeromonas phage (Prabhakaran et al. 2014). Such may be the case with
phiKZ and EL, where phiKZ’s larger set of tRNAs facilitates its discordance with host codon
usage and GC content. Further, the region of phiKZ’s genome containing its tRNAs accounts for
the majority of the size difference between phiKZ and EL’s genomes and is entirely unique to
phiKZ sharing no structural or sequence similarities with any regions of the EL genome
(Hertveldt et al. 2005). Thus the tRNA containing region of the phiKZ genome is the most
probable genomic attribute to account for major differences in host based selection pressure
faced by phage phiKZ and EL which otherwise have functionally highly similar genomes.
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The Effects of tRNA Availability on phiKZ and EL Codon Usage
At the forefront of apparent differences between phiKZ and EL that might lead to the observed
variation in their level of host dependence is their self-encoded tRNAs. EL encodes a single
tRNA for threonine, while phiKZ encodes six tRNAs for amino acids methionine, asparagine,
aspartic acid, threonine, proline, and leucine. While, both phage have a threonine tRNA, their
anticodons correspond to different codons: codon ACA for phiKZ and ACG for phage EL.
Differences in tRNA compliments between phage of similar composition is thought to result
from differences in host range or growth rate (Delesalle et al. 2016). phiKZ and EL have nearly
identical host range and growth rates so some other factor is likely to have influenced their
variable tRNA acquisition and maintenance.
In order to explore the influences of both self and host translational selection on the
codon usage of phage phiKZ and EL, the RSCU values calculated for the sense codons of each
phage were compared to the tRNA abundances of P. aeruginosa (Chan & Lowe 2009) and the
available phage tRNAs (each present in a single copy number). Results of this comparison are
shown in Table 6. Notably, phiKZ is computationally predicted to have a second copy of its
asparagine tRNA, shown in Figure 4, however to date this putative tRNA is not included in the
annotation of phiKZ’s genome and is therefore not considered in this analysis. For the purpose of
this comparison, tRNA abundance is considered to be directly proportional to tRNA copy
number, as is usually found to be the case in bacteria (Kanaya et al. 2001).
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AA

Codon

RSCU
phiKZ
1.17
0.83
2.08
0.41
1.14
0.3
1.67
0.4
1.77
0.82
0.41
1
1.75
0.32
1.52
0.41
1.52
0.48
1.52
0.48
1.37
0.63
1.47
0.53
1.39
0.61
1.64
0.36
1.52
0.48

EL
0.72
1.28
0.45
1.48
0.52
1.21
0.26
2.09
1.45
1.4
0.15
1
1.01
1.04
0.65
1.31
0.77
1.23
0.93
1.07
1.06
0.94
0.8
1.2
0.96
1.04
1.1
0.9
1.25
0.75

P. aeruginosa
tRNA copy
number

AA

Codon

RSCU

P. aeruginosa
tRNA copy
number

phiKZ EL
Phe
UUU
Ser UCU
1.58 0.76
UUC
1
UCC
0.39 1.19
1
Leu UUA*
UCA
1.63 0.42
1
UUG
1
UCG
0.28 1.04
1
CUU
Pro CCU
1.42 1.26
CUC
1
CCC
0.26 1.13
1
CUA
1
CCA* 1.88
0.4
1
CUG
2
CCG
0.45
1.2
1
Ile
AUU
Thr ACU
1.98 0.57
AUC
4
ACC
0.62 2.07
1
AUA
ACA* 1.15 0.35
1
†
Met AUG*
4
ACG
0.25
1
1
Val
GUU
Ala GCU
1.82 0.98
GUC
1
GCC
0.42 1.22
2
GUA
2
GCA
1.46 0.54
4
GUG
GCG
0.29 1.26
Tyr
UAU
Cys UGU
1.43 1.26
UAC
1
UGC
0.57 0.74
1
His
CAU
Trp UGG
1
1
1
CAC
2
Arg CGU
2.64 2.03
3
Gln
CAA
1
CGC
0.63 0.74
CAG
CGA
0.85 0.64
Asn
AAU
CGG
0.43
1.9
1
AAC*
2
AGA
0.83
0.3
1
Lys
AAA
2
AGG
0.62
0.4
1
AAG
Ser AGU
1.64 1.75
Asp
GAU
AGC
0.49 0.84
1
GAC*
4
Gly GGU
2.58 1.58
Glu
GAA
3
GGC
0.52 0.52
3
GAG
GGA
0.61 0.62
1
GGG
0.29 1.28
1
Table 6. Comparison of phiKZ and EL RSCU values with tRNA copy numbers in P. aeruginosa.
Codons indicated by an asterisk (UUA, AUG, AAC, GAC, CCA, and ACA) are recognized by
phiKZ tRNAs while the codon denoted by † (ACG) is recognized by the tRNA of EL.
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Twenty-six of phiKZ’s codons are used more often than expected (RSCU > 1), sixteen of
which are codons for which P. aeruginosa does not encode an isoreceptive tRNA. Additionally,
seven of the phiKZ codons corresponding to the twelve most abundant P. aeruginosa tRNAs,
those with two or more copies (excluding those for methionine), are underrepresented in phiKZ
(RSCU < 1). Two of these seven codons, aspartic acid codon GAC and asparagine codon AAC,
are also recognized by phiKZ’s self-encoded tRNAs. These results further indicate that phiKZ’s
codon usage does not demonstrate either strong translational selection or codon usage
correspondence with its host. Only phiKZ’s leucine tRNA isoreceptor is not also produced by P.
aeruginosa, indicating that in this case phage tRNAs do not appear to function primarily to
supplement for the absence of host isoreceptive tRNAs, although this may be the underlying
function of phiKZ’s leucine tRNA.
Only nine of the twenty-nine overrepresented EL sense codons are recognized by tRNAs
not encoded by P. aeruginosa, indicating that EL’s codon usage corresponds to host tRNA
availability to a greater extent than phiKZ’s. Further, seven of the twelve codons recognized by
P. aeruginosa’s most abundant tRNAs are overrepresented in the EL genome.
RSCU values of phiKZ and P. aeruginosa are compared to phiKZ’s available tRNAs in
Table 7. These data demonstrate that threonine, proline and leucine codons which correspond to
phiKZ’s tRNAs are all either underrepresented, and even rare in most cases (RSCU < 0.1), in the
host genome, both overall and among HEGs. The opposite applies to phiKZ’s asparagine and
aspartic acid tRNAs which each correspond to codons which are overrepresented in P.
aeruginosa but are underrepresented in phiKZ. phiKZ’s proline, leucine, and threonine codons
thus appear to boost translation of codons preferred in the phage but rarely used by the host.
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phiKZ’s asparagine and aspartic acid tRNAs have no clear relationship with phiKZ’s codon
usage.
Amino acid Anticodon
(5'-3')

Codon
(5'-3')

Threonine

ACA

UGU

Locus
(in bp)

phiKZ
RSCU

P. aeruginosa
RSCU
(Overall)
0.08

P. aeruginosa
RSCU
(HEG)
0.06

266,724 1.15
266,797
Asparagine
GUU
AAC
269,724 0.53
1.72
1.83
269,644
Aspartic
GUC
GAC
271,828 0.36
1.61
1.44
acid
271,899
Methionine
CAU
AUG
272,875 1
1
1
272,948
Proline
UGG
CCA
273,271 1.88
0.17
0.07
273,346
Leucine
UAA
UUA
273,359 2.08
0.01
0.01
273, 440
Table 7. phiKZ’s tRNAs compared with phiKZ and P. aeruginosa RSCU values for codons
recognized by phiKZ tRNAs. RSCU values for all P. aeruginosa genes and for HEGs are
included.

Threonine codon ACG which corresponds to EL’s self-encoded tRNA is used as often as
expected in the EL genome. A comparison of EL and host RSCU values for codon ACG are
shown in Table 8. These data indicate that codon ACG is underrepresented in the overall P.
aeruginosa genome and is rare in its high expression genes while ACG occurs as often as
expected in phage EL. These data indicate that EL’s tRNA may play a role in supplementing the
tRNA pool of the host for a codon utilized more by the phage than the host.
Amino
acid

Anticodon
(5'-3')

Codon
(5'-3')

EL RSCU

P. aeruginosa
RSCU
(Overall)

P. aeruginosa
RSCU
(HEG)

Threonine
CGU
ACG
1
0.61
0.12
Table 8. EL’s tRNA compared with EL and P. aeruginosa RSCU values for the codon
recognized by EL’s tRNA. RSCU values for all P. aeruginosa genes and for HEGs are included.
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These data demonstrate a mixed relationship between phage codon usage and their selfencoded tRNAs. The proline, leucine and threonine tRNAs of phiKZ and the threonine tRNA of
EL all appear to give the phage machinery to translate codons which are used significantly more
by the phage than the host. On the other hand, phiKZ’s asparagine and aspartic acid tRNAs
correspond to codons which are underrepresented in phiKZ and overrepresented in the host,
indicating that they do no function to optimize translation of their cognate codons. The majority
of phage tRNAs examined in this work appear to function to optimize translation of codons
preferentially used by the phage. Similar variable self-encoded tRNA usage has also been
observed for Mycobacterium phage Bxz1. Most Bxz1 tRNAs recognize codons preferentially
used by the phage while its other tRNAs correspond to codons used infrequently in both the
phage and its host (Sahu et al. 2004).
The codon usage within the phiKZ genome is an outlier to the common trend in phagehost codon usage correspondence (Carbone 2008, Lucks et al. 2008), although similar deviations
have been observed for some eukaryotic viruses (e.g., Gu et al. 2004). While phiKZ’s
discordance with its host’s codon usage is perhaps an anomaly, insight can be derived from
another phage with similarly mismatched phage-host codon usage – the Vibriophage KVP40
(Sau et al. 2007). Like phiKZ, KVP40 exhibits codon usage distinct from its Vibrio hosts, V.
cholera and V. parahaemolyticus (Matsuzaki et al. 1992). Notably, however, KVP40 has a much
broader known host range than phiKZ. In addition to its ability to infect multiple Vibrio spp.,
itself characteristic of a broad host-range phage, it can also infect Photobacterium leiognathi
species (Matsuzaki et al. 1992). Thus, perhaps its codon usage evolved to correspond with this
other host, or is an aggregate of the hosts it can infect. KVP40 encodes 25 functional tRNAs and
five pseudo-tRNAs. KVP40 has clear codon usage biases both for self tRNAs as well as Vibrio
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preferred tRNAs (Miller et al. 2003). This suggests that phage-encoded tRNAs may supplement
host translational machinery for phages which can infect across bacterial taxa. The presence of
the pseudo-tRNAs may be artifacts of past biosynthetic needs during infection of a former host
taxon. Thus it is reasonable to speculate that phiKZ may have a broader host range than is
currently recognized. While P. aeruginosa is the only host species identified for phiKZ to date,
phiKZ is unable to infect all P. aeruginosa strains. Moreover, phiKZ and its close relative
Pseudomonas phage KTN4 (>99% genome homology) differ in their ability to infect different P.
aeruginosa strains (Danis-Wlodarczyk et al. 2016). Based upon the results of the codon analysis
performed here, the host-range of phiKZ is called into question. Of particular interest would be
testing phiKZ’s ability to infect putative bacterial host taxa selected from their codon usage
correspondence with phiKZ.

CHAPTER FOUR
MUTANT PHAGE ENGINEERING AND EXPERIMENTAL EVOLUTION:
RESULTS & DISCUSSION
Strategy I: Engineering of phiKZ Mutants with Deoptimized Proline tRNAs
As the codon usage analyses found, the coding regions of phiKZ clearly favor the codon
CCA relative to CCC (Table 3). The phiKZ proline tRNA was thus targeted for engineering,
altering the anticodon from 5’-UGG-3’ to 5’-GGG-3’. Through this targeted engineering
strategy, the number of cognate tRNAs for the anticodon UGG is now zero as P. aeruginosa spp.
do not include a tRNA for this anticodon (Table 6) (Chan & Lowe 2009). The P. aeruginosa host
also includes a tRNA for the anticodon GGG. Consequently, if the phage is under translational
selection (utilizing available tRNAs), this engineered phiKZ strain will be under strong selection
to favor the codon GGG.
The region containing the proline tRNA was amplified and site directed mutagenesis was
successful in changing the anticodon sequence. This was confirmed by sequencing (the protocol
for engineering this tRNA is described in detail within Chapter Two). A number of restriction
digest designs were created in an effort to remove the section of phiKZ’s genome containing the
proline tRNA and replace it with the mutant version, however, the region of phiKZ’s genome
containing its tRNAs is bereft of restriction sites and the genome as a whole, due to its large size,
has only three restriction sites that occur fewer than fifteen times, making insertion of the mutant
proline tRNA by digest and ligation a design challenge.
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Restriction digest with SgsI, the only two-cutter in the phiKZ genome might be the most
promising option for replacing the wild type tRNA by the restriction and ligation method, as one
SgsI site occurs within the SuperPro mutant subsection of the phiKZ genome (the region
amplified and engineered) and the other occurs well outside the tRNA region. Digest with SgsI
splits the phiKZ genome into two large pieces, one ~50 Kbp in size, containing the tRNAs, and
the remainder of the genome in a ~230 Kbp section. Two digest approaches were designed for
paring down the resulting ~50 Kbp fragment in order to replace the section containing phiKZ’s
proline tRNA with the corresponding SuperPro mutant section. Details regarding the specific
protocols for each approach are detailed in Chapter Two. The first approach developed entailed
successfully recovering seven distinct fragments, the majority of which would have matching
SphI digested ends. Thus, the process of reassembling the genome via ligation, although feasible,
is thwarted by the fact that the fragments must ligate together in the correct order and orientation
in order for the phage to be viable. Therefore, the second approach was developed in which three
serial digestions would be performed. Accurately ligating the phage genome back together is
simplified by this approach as different restriction enzymes are used to generate each fragment,
giving each fragment a unique set of ends.
Given the greater likelihood of success with this second approach, it was explored. This
process, while circumventing the issues of the first approach, was highly contingent on being
able to retain DNA concentrations after a series of gel purifications as each digest would need to
be separated by gel and purified in preparation for the next digest/ligation. Thus, high
concentration stocks of phiKZ genomic DNA were produced for the initial digest. This is itself a
challenge. With each infected host cell, phiKZ typically produces relatively few progeny, an
aspect of viral fitness common amongst the Phikzviruses (Krylov & Zhazykov 1978, Danis-
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Wlodarczyk et al. 2016) and other large Pseudomonas-infecting phages (Lu et al. 2013). This is
the typical burst size for infection at MOI < 1-5. While a higher MOI increases the likelihood of
infection and thus the likelihood of more progeny, MOI > 5 has a drastic negative effect on
phage viability, the exact cause of which is a matter of conjecture. At these high MOI, phiKZ
transitions into a pseudolysogenic state, hypothesized to be the result of a change in the
conditions in DNA polymerase activity (Krylov et al. 2013), severely reducing viral production.
Through successive digests and purifications, which themselves lend to DNA loss, sufficient
concentrations of the required fragments were unable to be produced.
A more promising and less invasive method for insertion of a point mutation such as this
into a phage genome of this size is via homologous recombination. Phage are naturally prone to
both homologous and non-homologous recombination events; engineered phage can even be
used to induce recombination events in bacteria to generate mutations (Thomason et al. 2007). It
follows that phage might be used to mutate itself by recombination. Homologous recombination
between wild type phiKZ genomes and cloning vectors containing mutant tRNAs would be
expected to occur if the two were transformed into the same host and allowed to replicate
simultaneously. While recombination rates are generally infrequent (having a 5-30% chance of
success) for small mutations flanked by short, homologous ends, recombination in this instance
would involve swapping only a single point mutation located in a ~3 kb cloned region of the
viral genome (Thomason et al. 2007). This approach would require that selection for antibiotic
resistance be included such that only host cells including a plasmid harboring the engineered
phiKZ region are viable. Next, the phage would have to be capable of infecting these host cells
as changes in the efficacy of Pseudomonas phage has been observed as a result of the presence
of plasmids (Krylov et al. 2013).
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The greatest challenge of this technique would be identifying successfully mutated phage.
Populations grown in the presence of mutant vectors would need to be serially diluted in order to
isolate single PFUs. Plaques resulting from a single PFU would then be grown (ensuring the
presence of a single genotype), have their DNA extracted, and the mutation would be confirmed
by sequencing. Alternatively, recent attempts to incorporate fluorescent markers within phage
genomes could be explored (e.g., Vinay et al. 2015). While this would allow for expedient
recognition of engineered phage, the introduction of additional DNA could affect phage fitness
via unintended consequences of engineering (e.g. altered genome packaging, genome-capsid
interactions, and protein-protein interactions).
Strategy II: Duplicating a Subset of phiKZ tRNAs
Experimental Evolution of Engineered Phage
A population of phiKZ phage, B1, was engineered with a tandem duplication of a
subsection of the ancestral phage genome termed Looper. The Looper duplication is functionally
a 1,604 bp insertion in the phiKZ genome, giving phage populations with this mutation
additional copies of phiKZ’s aspartic acid, methionine, and proline tRNAs as well as phiKZ
ORFs 299, 300 and 301. This duplication is expected to be at least somewhat deleterious to the
phage as their increased genome size will increase replication time and has the potential to affect
the phage’s DNA packaging. Additionally, the Looper sequence includes three ORFs with
unknown functions with confirmed expression (NCBI record Accession: NC_004629.1). The
duplication of these ORFs may deleteriously affect phage fitness. The original map of the tRNArich region of the phiKZ genome (Figure 4) is now shown with the engineered duplicate in
Figure 12. It is worth noting that the putative second asparagine tRNA is not included within the
duplicated region; it occurs before the SgsI site in the amplicon.
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Figure 12. Engineered Looper duplication. The duplicated coding regions are indicated in blue.
In order to examine the effects of the Looper duplication on mutant phage populations,
six replicate lineages of the mutant B1 phage were serially transferred through naïve P.
aeruginosa populations in parallel with two control lineages of ancestral phiKZ. Five transfers
were conducted; phage were collected after 2.25 h of co-culture. This duration was specifically
selected as the ancestral phiKZ has a measured ‘generation’ (time from adsorption to burst) of
2.5 h (unpublished results). Transferring lysate at 2.25 h thus provides a selective advantage to
phage capable of translating efficiently and quickly lysing their host. Consequently, through the
experimental design itself, the phage were under selection for translational efficiency which in
turn should increase the likelihood of fixing mutations which confer a codon for which there are
more readily available tRNAs.
Comparative phage fitness was assessed by titering each population for all phage lineages
after each transfer. Dilution series for each successive transfer of both experimental and control
phage lineages were spotted onto P. aeruginosa lawns (see details in Chapter Two). The titer of
each phage population was calculated in PFU/ml from these dilution series as a means to track
phage fitness over time and to compare the fitness of B1 lineages with each other and the control
lines. Changes in phage titer over the course of the selection experiment are shown in Figure 13.
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Figure 13. Changes in phage titer over five transfers.
All phage lines, both experimental and control, were found to experience a similar drop
in the size of the phage population in culture following the third transfer. This drop is likely the
result of the experimental parameters imposing selection for a reduced generation time. The fact
that the control lines and replicate engineered lines drop at a similar rate suggests that this
decrease in the phage population cannot be attributed to the engineered mutation. It is likely that
the majority of phage had not yet completed lysis at the time of the second transfer, reducing
third transfer population sizes. After the third transfer, however, the control lines recovered as
did one of the six engineered lines, B1-1. By the next transfer, however, the engineered line
population again decreased. Greater reduction in titer among all of the B1 lineages compared to
the control lineages over the course of all five transfers is likely the result of reduced
translational efficiency among these phage as a result of their increased genome size. Tracking
the titers of B1 and ancestral phiKZ lines over more transfers would serve to further elucidate the
observed trends in phage fitness over time.
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Sixteen genes, listed in Table 2, which were expected to be among the most responsive
genes to the engineered tRNA duplications, were PCR amplified and sequenced from DNA
obtained from clonal plaques grown from isolates picked after plating the lysate of one B1
lineage collected after the fifth transfer. Genes of interest were either structural genes or genes
with RSCU<1 for codons correspondent to phiKZ’s aspartic acid and/or proline tRNAs.
Structural genes are expected be the most influenced by changes in translational pressure as prior
work found phage-host codon usage correspondence within structural genes to be greatest
(Carbone 2008). Synonymous mutations which increase the number of codons in structural genes
that are recognized by those tRNAs with abundances increased by the Looper mutation are
expected to have a fitness benefit for the phage by increasing both the rate and accuracy of these
genes’ translation.
Increased abundances of phiKZ’s aspartic acid and proline tRNAs are expected to
promote optimization of phage genes to these more available tRNAs and to relieve any selection
pressure preventing optimization of those phiKZ genes with RSCU<1 for codons corresponding
to these tRNAs. The codon usage of ancestral phiKZ populations indicates that phiKZ
preferentially uses codons corresponding to its proline tRNA but not its aspartic acid tRNA
(Table 3). Increased abundance of phiKZ’s proline tRNA in B1 mutants is expected to bolster
this preference. If the phage preferentially uses its tRNAs over those of the host, then increased
aspartic acid tRNA abundance in B1 is expected to promote the optimization of phage codon
usage to its aspartic acid tRNA via accumulation of synonymous mutations increasing the
number of codons correspondent to this tRNA.
Examination of the resulting sequence data found that no mutations occurred in any of
the samples obtained from the sequenced B1 replicate. While a rapid response to genetic
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engineering of codons was previously observed within 5 generations (Kula et al., unpublished
results), this was in a significantly smaller (5kbp) and single stranded DNA virus. phiKZ’s
larger, dsDNA genome, given its lower mutation rate (Sanjuán et al. 2010), did not respond to
selective pressure rapidly. Consequently, sequencing of the remaining engineered and control
lineages was not performed as all lineages are expected to bear similar results.
Predicted Responses to Genomic Engineering
Newly acquired mutations in the evolving B1 populations which compensate for any
deleterious effects of the Looper duplication will have a fitness advantage over competing B1
variants. Small populations of phage such as those used in the experimental evolution of B1 are
extremely competitive; phage variants that occur in sufficient numbers with beneficial mutations
are expected to quickly outcompete both other variants and the ancestral strain (Abedon 2008).
Any synonymous mutations which increase B1’s use of codons corresponding to the duplicated
aspartic acid and proline tRNAs are expected to be especially beneficial as use of more abundant
tRNAs is associated with increased translational speed and accuracy, which may compensate for
any fitness loss experienced by increased replication time.
Selective pressure to maximize fitness following a large insertion event and the
evolutionary bottlenecking of each phage population following each transfer into naïve host is
expected to accelerate the evolutionary rate of B1 phage populations (Bull et al. 2003). Further,
while there is no information available on the background mutation rates of giant dsDNA phage
such as phiKZ, smaller dsDNA phage T7 (~40 Kbp genome) populations have been found to
quickly accumulate mutations both under normal growth conditions (Yin 1998) and under
conditions of stress (Heineman & Brown 2012). Experimental evolution of phage has primarily
been performed in the small ssDNA phage phiX174 (e.g., Poon & Chao 2005, Domingo-Calap et
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al. 2009), which has also been found to rapidly accumulate mutations within short periods of
time (Bull et al. 2000). In contrast to phiKZ, phiX174 does not encode for its own tRNAs. Thus,
in an investigation of the role of selection for translational efficiency in phiX174, engineering
was performed to deoptimize the codon usage within its genes while tRNA availabilities were
maintained. This is a direct reversal of what was explored here, where the codon usage was
maintained but the tRNAs available were altered. Evolution of these engineered phiX174 lines
saw a rapid recovery of fitness and phage-host codon compatibility (Kula et al., unpublished
results). It is for this reason that the immediate response in phiKZ was studied here in detail.
Despite the expectation that both the experimental parameters used and selection pressure
to regain fitness following a probable deleterious mutation would promote rapid fixation of
beneficial synonymous mutations in the engineered phiKZ populations, no mutations were
identified among sixteen genes sequenced from one of the replicate B1 lineages. These results
indicate that even when grown under conditions that favor mutation, phiKZ evolves much more
slowly than phage with smaller genomes. Thus, if the effects of the engineered tRNA duplication
on phiKZ’s codon usage are to be observed, B1 populations will likely need to be grown over the
course of hundreds of generations. Although giant viruses like phiKZ have not previously been
evolved experimentally, leaving their mutation rates as yet undefined, mutation rates among
viruses are usually found to decline with increased genome size (Duffy et al. 2008); the largest
of the known giant viruses (mimiviruses with ~1.2 Mega base pair dsDNA genomes) may have
the lowest mutation rates among all viruses (Holmes 2011).
Future Directions
The B1 mutants engineered in this work provide the groundwork for an in-depth
examination of the effects of self-encoded tRNA abundance on the evolution of phage codon
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usage. The full effects of increased tRNA abundances on the codon usage of B1 may be
examined by the same methods utilized here, expanding the number of replicates and transfers
performed. Additionally, in depth fitness assays measuring the burst size of phage B1 and its
population doubling time will provide further insights into the fitness effects of the tRNA
engineering.
Importance of Examining phiKZ Evolution
Phage have become increasingly popular candidates for use either as alternatives or as
additives to antibiotics in medicine, food production industries, and agriculture with the growing
rise of multi antibiotic resistant bacteria. Medical use of phage therapy has become an especially
popular area of phage research. The use of phage to treat infections has a number of potential
benefits: phage are self-limiting, can be used locally rather than systemically, and they are host
specific (Clark & March 2006). Perhaps the greatest potential benefit of phage therapy is that
unlike conventional antibiotics phage can penetrate and break down biofilms (Nelson et al. 2001,
Glonti et al. 2010, Mills et al. 2013). Biofilm infections are particularly difficult to treat act as
the biofilm structure acts as a bacterial refuge that often prevents complete infection clearance,
leading to chronic infections and increased antibiotic resistance among those bacteria that
remain. Biofilms are notoriously difficult to treat (Donlan & Costerton 2002, Mills et al. 2013).
Phage have been found to be able to effectively penetrate or break down biofilms and can infect
both planktonic and vegetative cells (Glonti et al. 2010, Mills et al. 2013). Further, phage
cocktails can be used to effectively resolve multispecies biofilm infections (Knoll & Mylonakis
2014).
However, there a number of issues with phage therapy. First, bacteria are just as likely to
develop resistance to therapeutic phage mixtures as they are to antibiotics (Krylov et al. 2013).
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Phage themselves are highly antigenic so they may induce inflammatory responses in some
patients (Mills et al. 2013, Knoll & Mylonakis 2014, De Paepe et al. 2014), or may only be
effective in patients for a single use without stimulating immune system clearance of the phage
before it can work its way through the host population (Clark & March 2006). There is also
concern that phage lysis of some bacteria may release high concentrations of bacterial
endotoxins into the patient’s system, leading to toxicity and inflammation, especially in
immunocompromised patients (Knoll & Mylonakis 2014, Clark & March 2006). Phage
themselves have been found to be immunosupressive in some cases for mammal cells,
suppressing T cell and NFΚΒ cell activation, as well as both humoral and cell mediated immune
responses (Mills et al. 2013).
P. aeruginosa is at the forefront of proposed targets for phage therapy treatment (Glonti
et al. 2010, Murphy et al. 2013). P. aeruginosa causes a number of pulmonary infections in
immunocompromised individuals susceptible to opportunistic infections and is the predominant
cause of lung infections in cystic fibrosis patients (Mesyanzhinov et al. 2002). P. aeruginosa
forms mucous-like alginate biofilms that compound problems caused by the viscous, difficult to
expel mucus that is phenotypic of cystic fibrosis. The mucus and biofilm act synergistically to
protect the bacteria from patients’ immune systems and any administered antimicrobials (Glonti
et al. 2010). Further complicating matters, P. aeruginosa has become increasingly resistant to
multiple antibiotics including penicillins, cephalosporins, tetraclines, and vancomycin
(Mesyanzhinov et al. 2002, Krylov et al. 2013). phiKZ is widely considered the most promising
candidate for use in phage therapy against Pseudomonas infections due to its ability to infect up
to 50% of known P. aeruginosa strains (Krylov et al. 2003) and because it can be grown and
purified at high titer with minimal cost (Mesyanzhinov et al. 2002). Recent work with a phiKZ-
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like virus, OMKO1, presents an interesting phage-antibiotic combination approach of combatting
P. aeruginosa infections in which phage selection produced an evolutionary trade-off: resistance
to phage increased sensitivity to antibiotics (Chan et al. 2016).
The greatest issue facing phage therapy is our lack of knowledge regarding phage
ecology and evolution. As previously noted, the majority of known phages remain only partially
characterized and utilize only a small set of model hosts. Use of phage therapy against a broad
range of pathogenic bacteria will not be feasible until more is understood about phage genome
structure and how to identify and functionally annotate phage genes. While phage genomes
remain cryptic and phage ecology poorly examined, large scale implementation of phage as
antibacterial agents in medicine, agriculture and industry is premature at best as the effects of
introducing dense phage populations into the human body or the environment are not yet reliably
predictable. If phage are ever to become viable antibacterial agents, studies in phage must
become broader in scope, expanding well beyond those phage occupying laboratory model hosts.

CHAPTER FIVE
CONCLUSIONS
Phage, being almost entirely dependent on their hosts’ translational machinery are usually found
to have similar codon usage biases as those of their hosts, although this is not always the case.
Codon usage analysis of the giant P. aeruginosa phages Pseudomonas phage phiKZ and
Pseudomonas phage EL performed here demonstrates that despite sharing a host and having
similar proteomes, the codon usage of these phage is shaped by distinct forms of selection. The
analyses performed here demonstrate that phiKZ’s codon usage is primarily determined by its
strongly AT enriched composition whereas EL’s codon usage appears to be largely shaped by
translational selection to use codons preferentially utilized by its host. phiKZ’s greater
independence from host selection pressure compared to phage EL may in part be explained by
phiKZ’s larger compliment of tRNAs. Indeed, phiKZ’s threonine, proline and leucine tRNAs
were found to correspond to codons which are preferentially used in phiKZ but which are
conspicuously rare in the host. phiKZ’s tRNAs alone do not account for the extreme disparity
observed between its codon usage and that of P. aeruginosa, perhaps indicating that phiKZ’s
codon usage is shaped by a broader host-range than previously thought.
The phiKZ strain engineered with duplicated aspartic acid, methionine, and proline
tRNAs provides a mechanism to study the effects on tRNA abundance and selection for
translational efficiency. Furthermore, the selection experiment was designed to increase selection
for translational efficiency by propagating only those virions which were efficient in their
81
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infection of the host. Substantial reductions in phage titer produced by replicate B1 lineages over
the course of five transfers indicate that the experimental regime was effective in increasing
selection for translational efficiency. This is supported by the observation that these reductions
occurred both within the control and engineered phiKZ lines. Following five transfers, no
mutations were found to have occurred in phiKZ genes with codon usage expected to be
especially influenced by translational selection, providing experimental evidence that giant
dsDNA viruses like phiKZ have lower mutation rates than their smaller relatives. Due to
phiKZ’s slow evolutionary rate, evaluation of the effects of the engineered tRNA duplication
will necessitate long term evolution of B1 lineages. Experimental evolution such as this has the
potential to examine the unique constraints of phage-encoded tRNAs on viral fecundity. Use of
Pseudomonas phage phiKZ is particularly attractive for such work given its potential use in
phage therapy.

APPENDIX A
258 PHIKZ GENES SELECTED FOR CODON USAGE ANALYSIS
(STRUCTURAL GENES INDICATED IN BOLD)
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Gene
1
2
3
4
5
6
7
8
9
10
14
15
16
17
18
19
22
25
26
27
28
29
30
31
32
33
34
35
37
39
48
49
50
51
52
53
54
55
58

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Tail protein
Capsid protein
Tail protein
Tail sheath protein
Predicted protein
Capsid protein
Predicted protein
Tail tube protein
Capsid protein
RNA Degradosome Inhibitor
Tubulin FtsZ / GTPase
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Capsid protein
Predicted protein
Predicted protein
Major non-virion RNA
polymerase protein
Predicted protein

Gene
153
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
180
181
182
183
184
186
187
188
189
190
191
194
195
197
198

Predicted Function
Tail protein
Tail protein
Predicted protein
Predicted protein
Tail protein
Predicted protein
Inner Body protein
Inner Body protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Prohead Protease
Capsid protein
Capsid protein
Capsid protein
Virion RNA Polymerase Beta Subunit
Tail protein
Predicted protein
Predicted protein
Penetrative endolysin (tail needle)
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

199

Predicted protein
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Gene
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Minor non-virion RNA
polymerase protein
Predicted protein
Predicted protein
Minor non-virion RNA
polymerase protein
Minor non-virion RNA
polymerase protein
Minor non-virion RNA
polymerase protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Capsid protein
Capsid protein
Predicted protein
Predicted protein
Capsid protein
Capsid protein
Tail protein
Capsid protein
Tail protein
Predicted protein
Inner Body protein
Inner Body protein
Tail protein
Inner Body protein
Inner Body protein
Inner Body protein
Inner Body protein

Gene
200
201
202
203
204
205
206
207
208
209

Predicted Function
Predicted protein
Tail protein
Tail protein
Capsid protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

210
211
212

Predicted protein
Predicted protein
Predicted protein

213

Predicted protein

214

Predicted protein

215
216
217
218
219
220
221
222
223
224
226
227
228
229
230
231
232
233
234
235
242

Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

86
Gene
96
97
98
99
100
101
102
103
104
106
107
108
109
110
111
112
113
115
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136

Predicted Function
Capsid protein
Inner Body protein
Predicted protein
Capsid protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Major capsid protein (most
abundant protein)
Predicted protein
Predicted protein
Major non-virion RNA
polymerase protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Capsid protein
Portal protein
Tail protein
Tail protein
Tail protein
Tail protein
Tail protein
Tail protein
Predicted protein

Gene
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
260
262
263
264
265
266

Predicted Function
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

267
268
269

Predicted protein
Predicted protein
Predicted protein

270
272
274
275
276
277
278
279
280
281
282
283
284

Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
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Gene
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152

Predicted Function
Predicted protein
Predicted protein
Tail protein
Predicted protein
Predicted protein
Predicted protein
Tail protein
Lytic endolysin
Minor capsid protein
(second most abundant
protein)
Capsid protein
Predicted protein
Predicted protein
Capsid protein
Predicted protein
Predicted protein
Predicted protein

Gene
285
286
287
288
289
290
291
293
298

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Tail protein

299
300
301
302
304
305
306

Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

APPENDIX B
166 EL GENES SELECTED FOR CODON USAGE ANALYSIS
(STRUCTURAL GENES IN BOLD)
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89
Gene
2
3
4
5
6
7
8
9
10
12
13
14
15
17
18
19
21
22
23
26
28
29
30
31
32
34
35
36
38
41
42
43
44
45
46
47
48
51
52

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
DNA polymerase
Structural protein
Predicted protein
Predicted protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein

Gene
106
107
108
110
111
112
113
114
115
116
117
119
121
122
123
125
126
127
128
129
130
131
132
133
134
135
136
138
139
140
141
142
143
144
145
146
147
148
149

Predicted Function
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Tail fiber protein
Tail fiber protein
Tail fiber protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
GroEL-like chaperonin
Predicted protein
Structural protein
Predicted protein
Predicted protein
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Gene
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
75
76
77
78
79
80
81
82
83
85
86
87
90
91
92
93
95
96
98

Predicted Function
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Minor capsid protein
Structural protein
Predicted protein
Structural protein
Predicted protein
Structural protein
Structural protein
Predicted protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Major capsid protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein

Gene
150
151
152
153
154
155
156
157
158
159
162
163
164
165
167
168
169
170
171
172
173
175
176
177
178
179
180
181
182
183
184
186
188
189
190
191
193
194
196

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Predicted protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Structural protein
Predicted protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Structural protein
Predicted protein
Predicted protein
Predicted protein
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Gene
99
100
103
104
105

Predicted Function
Predicted protein
Predicted protein
Structural protein
Structural protein
Predicted protein

Gene
197
198
199
200
201

Predicted Function
Predicted protein
Predicted protein
Predicted protein
Predicted protein
Predicted protein
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